Page Numbers | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 1. | |||
Item 2. | |||
Item 6. | |||
PART I. | FINANCIAL INFORMATION |
ITEM 1. | FINANCIAL STATEMENTS |
March 31, 2016 | December 31, 2015 | ||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash and cash equivalents | $ | 247.9 | $ | 426.7 | |||
Accounts and notes receivable, net | 942.5 | 836.8 | |||||
Inventories, net | 1,725.8 | 1,423.4 | |||||
Other current assets | 296.9 | 211.4 | |||||
Total current assets | 3,213.1 | 2,898.3 | |||||
Property, plant and equipment, net | 1,380.0 | 1,347.1 | |||||
Investment in affiliates | 419.0 | 392.9 | |||||
Deferred tax assets | 110.1 | 100.7 | |||||
Other assets | 149.2 | 136.5 | |||||
Intangible assets, net | 535.6 | 507.7 | |||||
Goodwill | 1,169.2 | 1,114.5 | |||||
Total assets | $ | 6,976.2 | $ | 6,497.7 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current Liabilities: | |||||||
Current portion of long-term debt | $ | 93.1 | $ | 89.0 | |||
Senior term loan | 227.8 | 217.2 | |||||
Accounts payable | 673.9 | 625.6 | |||||
Accrued expenses | 1,065.8 | 1,106.9 | |||||
Other current liabilities | 202.7 | 146.7 | |||||
Total current liabilities | 2,263.3 | 2,185.4 | |||||
Long-term debt, less current portion and debt issuance costs | 1,257.5 | 925.2 | |||||
Pensions and postretirement health care benefits | 231.2 | 233.9 | |||||
Deferred tax liabilities | 95.5 | 86.4 | |||||
Other noncurrent liabilities | 195.3 | 183.5 | |||||
Total liabilities | 4,042.8 | 3,614.4 | |||||
Commitments and contingencies (Note 17) | |||||||
Stockholders’ Equity: | |||||||
AGCO Corporation stockholders’ equity: | |||||||
Preferred stock; $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding in 2016 and 2015 | — | — | |||||
Common stock; $0.01 par value, 150,000,000 shares authorized, 82,458,100 and 83,814,809 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively | 0.8 | 0.8 | |||||
Additional paid-in capital | 246.3 | 301.7 | |||||
Retained earnings | 3,993.0 | 3,996.0 | |||||
Accumulated other comprehensive loss | (1,365.9 | ) | (1,460.2 | ) | |||
Total AGCO Corporation stockholders’ equity | 2,874.2 | 2,838.3 | |||||
Noncontrolling interests | 59.2 | 45.0 | |||||
Total stockholders’ equity | 2,933.4 | 2,883.3 | |||||
Total liabilities and stockholders’ equity | $ | 6,976.2 | $ | 6,497.7 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Net sales | $ | 1,559.3 | $ | 1,702.6 | |||
Cost of goods sold | 1,244.6 | 1,354.7 | |||||
Gross profit | 314.7 | 347.9 | |||||
Selling, general and administrative expenses | 211.2 | 211.2 | |||||
Engineering expenses | 71.2 | 68.8 | |||||
Restructuring and other infrequent expenses | 1.9 | 10.6 | |||||
Amortization of intangibles | 11.0 | 10.5 | |||||
Income from operations | 19.4 | 46.8 | |||||
Interest expense, net | 10.5 | 10.2 | |||||
Other expense, net | 11.3 | 9.8 | |||||
(Loss) income before income taxes and equity in net earnings of affiliates | (2.4 | ) | 26.8 | ||||
Income tax (benefit) provision | (0.4 | ) | 10.6 | ||||
(Loss) income before equity in net earnings of affiliates | (2.0 | ) | 16.2 | ||||
Equity in net earnings of affiliates | 12.2 | 13.7 | |||||
Net income | 10.2 | 29.9 | |||||
Net (income) loss attributable to noncontrolling interests | (2.4 | ) | 0.2 | ||||
Net income attributable to AGCO Corporation and subsidiaries | $ | 7.8 | $ | 30.1 | |||
Net income per common share attributable to AGCO Corporation and subsidiaries: | |||||||
Basic | $ | 0.09 | $ | 0.34 | |||
Diluted | $ | 0.09 | $ | 0.34 | |||
Cash dividends declared and paid per common share | $ | 0.13 | $ | 0.12 | |||
Weighted average number of common and common equivalent shares outstanding: | |||||||
Basic | 83.0 | 88.8 | |||||
Diluted | 83.1 | 89.0 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Net income | $ | 10.2 | $ | 29.9 | |||
Other comprehensive income (loss), net of reclassification adjustments: | |||||||
Foreign currency translation adjustments | 94.8 | (344.2 | ) | ||||
Defined benefit pension plans, net of tax | 2.2 | 2.2 | |||||
Unrealized loss on derivatives, net of tax | (2.7 | ) | (1.6 | ) | |||
Other comprehensive income (loss), net of reclassification adjustments | 94.3 | (343.6 | ) | ||||
Comprehensive income (loss) | 104.5 | (313.7 | ) | ||||
Comprehensive (income) loss attributable to noncontrolling interests | (2.4 | ) | 0.1 | ||||
Comprehensive income (loss) attributable to AGCO Corporation and subsidiaries | $ | 102.1 | $ | (313.6 | ) |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 10.2 | $ | 29.9 | |||
Adjustments to reconcile net income to net cash used in operating activities: | |||||||
Depreciation | 55.5 | 54.1 | |||||
Deferred debt issuance cost amortization | 0.4 | 0.4 | |||||
Amortization of intangibles | 11.0 | 10.5 | |||||
Stock compensation | 5.5 | 2.4 | |||||
Equity in net earnings of affiliates, net of cash received | (8.3 | ) | (12.5 | ) | |||
Deferred income tax provision | (8.7 | ) | (2.8 | ) | |||
Other | (0.1 | ) | (0.1 | ) | |||
Changes in operating assets and liabilities, net of effects from purchase of businesses: | |||||||
Accounts and notes receivable, net | (57.2 | ) | (167.9 | ) | |||
Inventories, net | (214.9 | ) | (239.8 | ) | |||
Other current and noncurrent assets | (66.9 | ) | (46.4 | ) | |||
Accounts payable | 8.3 | 174.0 | |||||
Accrued expenses | (80.1 | ) | (89.9 | ) | |||
Other current and noncurrent liabilities | (2.9 | ) | 2.1 | ||||
Total adjustments | (358.4 | ) | (315.9 | ) | |||
Net cash used in operating activities | (348.2 | ) | (286.0 | ) | |||
Cash flows from investing activities: | |||||||
Purchases of property, plant and equipment | (35.7 | ) | (62.9 | ) | |||
Proceeds from sale of property, plant and equipment | 0.5 | 0.4 | |||||
Purchase of businesses, net of cash acquired | (38.8 | ) | — | ||||
Investment in consolidated affiliates, net of cash acquired | (11.8 | ) | — | ||||
Investment in unconsolidated affiliates | — | (5.2 | ) | ||||
Restricted cash | (0.3 | ) | — | ||||
Net cash used in investing activities | (86.1 | ) | (67.7 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from debt obligations, net | 317.5 | 445.8 | |||||
Purchases and retirement of common stock | (60.0 | ) | (62.5 | ) | |||
Payment of dividends to stockholders | (10.8 | ) | (10.7 | ) | |||
Payment of minimum tax withholdings on stock compensation | (0.8 | ) | (5.7 | ) | |||
Net cash provided by financing activities | 245.9 | 366.9 | |||||
Effects of exchange rate changes on cash and cash equivalents | 9.6 | (38.0 | ) | ||||
Decrease in cash and cash equivalents | (178.8 | ) | (24.8 | ) | |||
Cash and cash equivalents, beginning of period | 426.7 | 363.7 | |||||
Cash and cash equivalents, end of period | $ | 247.9 | $ | 338.9 |
• | In March 2016, the FASB issued ASU 2016-08, “Principal versus Agent Considerations (Reporting Revenue Gross versus Net)” (“ASU 2016-08”), which clarifies the implementation guidance on principal versus agent considerations as set forth in ASU 2014-09. |
• | In April 2016, the FASB issued ASU 2016-10, “Identifying Performance Obligations and Licensing” (“ASU 2016-10”), which clarifies the implementation guidance on identifying performance obligations and licensing as set forth in ASU 2014-09. |
Intangible Asset | Amount | Weighted-Average Useful Life | |||||
Customer relationships | $ | 15.7 | 10 | years | |||
Technology | 7.9 | 10 | years | ||||
Trademarks | 3.9 | 10 | years | ||||
$ | 27.5 |
Three Months Ended March 31, | ||||||||
2016 | 2015 | |||||||
Cost of goods sold | $ | 0.4 | $ | 0.2 | ||||
Selling, general and administrative expenses | 5.1 | 2.2 | ||||||
Total stock compensation expense | $ | 5.5 | $ | 2.4 |
Shares awarded but not earned at January 1 | 1,449,396 | |
Shares awarded | 1,327,042 | |
Shares forfeited or unearned | (11,248 | ) |
Shares earned | — | |
Shares awarded but not earned at March 31 | 2,765,190 |
Shares awarded but not vested at January 1 | 137,396 | |
Shares awarded | 137,496 | |
Shares forfeited | (1,358 | ) |
Shares vested | (46,137 | ) |
Shares awarded but not vested at March 31 | 227,397 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Weighted average grant-date fair value | $ | 7.98 | $ | 7.41 | |||
Weighted average assumptions under Black-Scholes option pricing model: | |||||||
Expected life of awards (years) | 3.0 | 3.0 | |||||
Risk-free interest rate | 1.1 | % | 0.9 | % | |||
Expected volatility | 25.9 | % | 25.9 | % | |||
Expected dividend yield | 1.1 | % | 1.1 | % |
SSARs outstanding at January 1 | 1,319,911 | ||
SSARs granted | 296,200 | ||
SSARs exercised | (375 | ) | |
SSARs canceled or forfeited | (4,400 | ) | |
SSARs outstanding at March 31 | 1,611,336 | ||
SSAR price ranges per share: | |||
Granted | $ | 46.58 | |
Exercised | 33.65 | ||
Canceled or forfeited | 51.84-55.23 | ||
Weighted average SSAR exercise prices per share: | |||
Granted | $ | 46.58 | |
Exercised | 33.65 | ||
Canceled or forfeited | 53.15 | ||
Outstanding at March 31 | 49.00 |
SSARs Outstanding | SSARs Exercisable | |||||||||||||||
Range of Exercise Prices | Number of Shares | Weighted Average Remaining Contractual Life (Years) | Weighted Average Exercise Price | Number of Shares | Weighted Average Exercise Price | |||||||||||
$32.01 – $43.88 | 428,650 | 4.5 | $ | 41.26 | 191,075 | $ | 37.99 | |||||||||
$46.58 – $63.64 | 1,182,686 | 4.4 | $ | 51.81 | 671,415 | $ | 53.18 | |||||||||
1,611,336 | 862,490 | $ | 49.81 |
Trademarks and Tradenames | Customer Relationships | Patents and Technology | Land Use Rights | Total | |||||||||||||||
Gross carrying amounts: | |||||||||||||||||||
Balance as of December 31, 2015 | $ | 122.2 | $ | 492.3 | $ | 92.5 | $ | 9.1 | $ | 716.1 | |||||||||
Acquisitions | 5.2 | 18.6 | 9.8 | — | 33.6 | ||||||||||||||
Foreign currency translation | 0.9 | 7.1 | 2.4 | 0.1 | 10.5 | ||||||||||||||
Balance as of March 31, 2016 | $ | 128.3 | $ | 518.0 | $ | 104.7 | $ | 9.2 | $ | 760.2 |
Trademarks and Tradenames | Customer Relationships | Patents and Technology | Land Use Rights | Total | |||||||||||||||
Accumulated amortization: | |||||||||||||||||||
Balance as of December 31, 2015 | $ | 41.9 | $ | 193.8 | $ | 55.1 | $ | 2.9 | $ | 293.7 | |||||||||
Amortization expense | 1.8 | 8.0 | 1.2 | — | 11.0 | ||||||||||||||
Foreign currency translation | — | 4.8 | 1.9 | — | 6.7 | ||||||||||||||
Balance as of March 31, 2016 | $ | 43.7 | $ | 206.6 | $ | 58.2 | $ | 2.9 | $ | 311.4 |
Trademarks and Tradenames | |||
Indefinite-lived intangible assets: | |||
Balance as of December 31, 2015 | $ | 85.3 | |
Foreign currency translation | 1.5 | ||
Balance as of March 31, 2016 | $ | 86.8 |
North America | South America | Europe/Africa/ Middle East | Asia/ Pacific | Consolidated | |||||||||||||||
Balance as of December 31, 2015 | $ | 518.7 | $ | 114.4 | $ | 425.2 | $ | 56.2 | $ | 1,114.5 | |||||||||
Acquisitions | 16.4 | — | 8.4 | — | 24.8 | ||||||||||||||
Foreign currency translation | — | 11.5 | 15.9 | 2.5 | 29.9 | ||||||||||||||
Balance as of March 31, 2016 | $ | 535.1 | $ | 125.9 | $ | 449.5 | $ | 58.7 | $ | 1,169.2 |
March 31, 2016 | December 31, 2015 | ||||||
41/2% Senior term loan due 2016 | $ | 227.8 | $ | 217.2 | |||
Credit facility, expiring 2020 | 658.5 | 338.9 | |||||
1.056% Senior term loan due 2020 | 227.8 | 217.2 | |||||
57/8% Senior notes due 2021 | 307.5 | 297.4 | |||||
Other long-term debt | 160.3 | 164.3 | |||||
Debt issuance costs | (3.5 | ) | (3.6 | ) | |||
1,578.4 | 1,231.4 | ||||||
Less: 41/2% Senior term loan due 2016 | (227.8 | ) | (217.2 | ) | |||
Current portion of other long-term debt | (93.1 | ) | (89.0 | ) | |||
Total indebtedness, less current portion | $ | 1,257.5 | $ | 925.2 |
March 31, 2016 | December 31, 2015 | ||||||
Finished goods | $ | 688.6 | $ | 523.1 | |||
Repair and replacement parts | 568.1 | 515.4 | |||||
Work in process | 130.4 | 97.5 | |||||
Raw materials | 338.7 | 287.4 | |||||
Inventories, net | $ | 1,725.8 | $ | 1,423.4 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Balance at beginning of period | $ | 230.3 | $ | 284.6 | |||
Acquisitions | 0.6 | — | |||||
Accruals for warranties issued during the period | 44.0 | 34.0 | |||||
Settlements made (in cash or in kind) during the period | (40.6 | ) | (44.9 | ) | |||
Foreign currency translation | 7.4 | (20.8 | ) | ||||
Balance at March 31 | $ | 241.7 | $ | 252.9 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Basic net income per share: | |||||||
Net income attributable to AGCO Corporation and subsidiaries | $ | 7.8 | $ | 30.1 | |||
Weighted average number of common shares outstanding | 83.0 | 88.8 | |||||
Basic net income per share attributable to AGCO Corporation and subsidiaries | $ | 0.09 | $ | 0.34 | |||
Diluted net income per share: | |||||||
Net income attributable to AGCO Corporation and subsidiaries | $ | 7.8 | $ | 30.1 | |||
Weighted average number of common shares outstanding | 83.0 | 88.8 | |||||
Dilutive SSARs, performance share awards and restricted stock units | 0.1 | 0.2 | |||||
Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income per share | 83.1 | 89.0 | |||||
Diluted net income per share attributable to AGCO Corporation and subsidiaries | $ | 0.09 | $ | 0.34 |
Before-Tax Amount | Income Tax | After-Tax Amount | ||||||||||
Accumulated derivative net losses as of December 31, 2015 | $ | (3.3 | ) | $ | (1.3 | ) | $ | (2.0 | ) | |||
Net changes in fair value of derivatives | (4.8 | ) | (1.9 | ) | (2.9 | ) | ||||||
Net losses reclassified from accumulated other comprehensive loss into income | 0.4 | 0.2 | 0.2 | |||||||||
Accumulated derivative net losses as of March 31, 2016 | $ | (7.7 | ) | $ | (3.0 | ) | $ | (4.7 | ) |
Asset Derivatives as of March 31, 2016 | Liability Derivatives as of March 31, 2016 | ||||||||||
Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||
Derivative instruments designated as hedging instruments: | |||||||||||
Interest rate swap contracts | Other noncurrent assets | $ | 7.5 | Other noncurrent liabilities | $ | 7.8 | |||||
Derivative instruments not designated as hedging instruments: | |||||||||||
Foreign currency contracts | Other current assets | 10.9 | Other current liabilities | 13.7 | |||||||
Total derivative instruments | $ | 18.4 | $ | 21.5 |
Asset Derivatives as of December 31, 2015 | Liability Derivatives as of December 31, 2015 | ||||||||||
Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||
Derivative instruments designated as hedging instruments: | |||||||||||
Interest rate swap contracts | Other current assets | $ | — | Other current liabilities | $ | 5.9 | |||||
Derivative instruments not designated as hedging instruments: | |||||||||||
Foreign currency contracts | Other current assets | 4.8 | Other current liabilities | 7.9 | |||||||
Total derivative instruments | $ | 4.8 | $ | 13.8 |
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interests | Total Stockholders’ Equity | ||||||||||||||||||
Balance, December 31, 2015 | $ | 0.8 | $ | 301.7 | $ | 3,996.0 | $ | (1,460.2 | ) | $ | 45.0 | $ | 2,883.3 | ||||||||||
Stock compensation | — | 5.5 | — | — | — | 5.5 | |||||||||||||||||
Issuance of restricted stock units | — | (0.9 | ) | — | — | — | (0.9 | ) | |||||||||||||||
Comprehensive income: | |||||||||||||||||||||||
Net income | — | — | 7.8 | — | 2.4 | 10.2 | |||||||||||||||||
Other comprehensive income, net of reclassification adjustments: | |||||||||||||||||||||||
Foreign currency translation adjustments | — | — | — | 94.8 | — | 94.8 | |||||||||||||||||
Defined benefit pension plans, net of tax | — | — | — | 2.2 | — | 2.2 | |||||||||||||||||
Unrealized loss on derivatives, net of tax | — | — | — | (2.7 | ) | — | (2.7 | ) | |||||||||||||||
Payment of dividends to stockholders | — | — | (10.8 | ) | — | — | (10.8 | ) | |||||||||||||||
Purchases and retirement of common stock | — | (60.0 | ) | — | — | — | (60.0 | ) | |||||||||||||||
Investment by noncontrolling interest | — | — | — | — | 11.8 | 11.8 | |||||||||||||||||
Balance, March 31, 2016 | $ | 0.8 | $ | 246.3 | $ | 3,993.0 | $ | (1,365.9 | ) | $ | 59.2 | $ | 2,933.4 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Net income (loss) | $ | 2.4 | $ | (0.2 | ) | ||
Other comprehensive income: | |||||||
Foreign currency translation adjustments | — | 0.1 | |||||
Total comprehensive income (loss) | $ | 2.4 | $ | (0.1 | ) |
Defined Benefit Pension Plans | Deferred Net (Losses) Gains on Derivatives | Cumulative Translation Adjustment | Total | ||||||||||||
Accumulated other comprehensive loss, December 31, 2015 | $ | (249.0 | ) | $ | (2.0 | ) | $ | (1,209.2 | ) | $ | (1,460.2 | ) | |||
Other comprehensive (loss) income before reclassifications | — | (2.9 | ) | 94.8 | 91.9 | ||||||||||
Net losses reclassified from accumulated other comprehensive loss | 2.2 | 0.2 | — | 2.4 | |||||||||||
Other comprehensive income (loss), net of reclassification adjustments | 2.2 | (2.7 | ) | 94.8 | 94.3 | ||||||||||
Accumulated other comprehensive loss, March 31, 2016 | $ | (246.8 | ) | $ | (4.7 | ) | $ | (1,114.4 | ) | $ | (1,365.9 | ) |
Amount Reclassified from Accumulated Other Comprehensive Loss | Affected Line Item within the Condensed Consolidated Statements of Operations | ||||||||
Details about Accumulated Other Comprehensive Loss Components | Three months ended March 31, 2016 (1) | Three months ended March 31, 2015 (1) | |||||||
Derivatives: | |||||||||
Net losses on foreign currency contracts | $ | — | $ | 0.3 | Cost of goods sold | ||||
Net losses on interest rate swap contracts | 0.4 | — | Interest expense, net | ||||||
Reclassification before tax | 0.4 | 0.3 | |||||||
(0.2 | ) | — | Income tax provision | ||||||
Reclassification net of tax | $ | 0.2 | $ | 0.3 | |||||
Defined benefit pension plans: | |||||||||
Amortization of net actuarial loss | $ | 2.6 | $ | 2.8 | (2) | ||||
Amortization of prior service cost | 0.3 | 0.1 | (2) | ||||||
Reclassification before tax | 2.9 | 2.9 | |||||||
(0.7 | ) | (0.7 | ) | Income tax provision | |||||
Reclassification net of tax | $ | 2.2 | $ | 2.2 | |||||
Net losses reclassified from accumulated other comprehensive loss | $ | 2.4 | $ | 2.5 |
Three Months Ended March 31, | ||||||||
Pension benefits | 2016 | 2015 | ||||||
Service cost | $ | 4.1 | $ | 4.7 | ||||
Interest cost | 6.4 | 7.8 | ||||||
Expected return on plan assets | (10.2 | ) | (11.1 | ) | ||||
Amortization of net actuarial loss | 2.6 | 2.8 | ||||||
Amortization of prior service cost | 0.3 | 0.1 | ||||||
Net periodic pension cost | $ | 3.2 | $ | 4.3 |
Three Months Ended March 31, | ||||||||
Postretirement benefits | 2016 | 2015 | ||||||
Interest cost | $ | 0.4 | $ | 0.4 | ||||
Net periodic postretirement benefit cost | $ | 0.4 | $ | 0.4 |
Before-Tax Amount | Income Tax | After-Tax Amount | ||||||||||
Accumulated other comprehensive loss as of December 31, 2015 | $ | (336.6 | ) | $ | (87.6 | ) | $ | (249.0 | ) | |||
Amortization of net actuarial loss | 2.6 | 0.6 | 2.0 | |||||||||
Amortization of prior service cost | 0.3 | 0.1 | 0.2 | |||||||||
Accumulated other comprehensive loss as of March 31, 2016 | $ | (333.7 | ) | $ | (86.9 | ) | $ | (246.8 | ) |
As of March 31, 2016 | ||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||
Derivative assets | $ | — | $ | 18.4 | $ | — | $ | 18.4 | ||||
Derivative liabilities | $ | — | $ | 21.5 | $ | — | $ | 21.5 | ||||
Long-term debt | $ | — | $ | 307.5 | $ | — | $ | 307.5 | ||||
Trading securities | $ | — | $ | 7.2 | $ | — | $ | 7.2 |
As of December 31, 2015 | ||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||
Derivative assets | $ | — | $ | 4.8 | $ | — | $ | 4.8 | ||||
Derivative liabilities | $ | — | $ | 13.8 | $ | — | $ | 13.8 | ||||
Long-term debt | $ | — | $ | 297.4 | $ | — | $ | 297.4 | ||||
Trading securities | $ | — | $ | 6.6 | $ | — | $ | 6.6 |
Three Months Ended March 31, | North America | South America | Europe/Africa/ Middle East | Asia/ Pacific | Consolidated | |||||||||||||||
2016 | ||||||||||||||||||||
Net sales | $ | 408.4 | $ | 144.2 | $ | 924.1 | $ | 82.6 | $ | 1,559.3 | ||||||||||
(Loss) income from operations | (0.7 | ) | 0.4 | 70.3 | (2.9 | ) | 67.1 | |||||||||||||
Depreciation | 15.6 | 4.6 | 31.7 | 3.6 | 55.5 | |||||||||||||||
Capital expenditures | 11.4 | 6.2 | 15.7 | 2.4 | 35.7 | |||||||||||||||
2015 | ||||||||||||||||||||
Net sales | $ | 472.5 | $ | 249.0 | $ | 908.1 | $ | 73.0 | $ | 1,702.6 | ||||||||||
Income (loss) from operations | 17.5 | 13.1 | 80.5 | (12.0 | ) | 99.1 | ||||||||||||||
Depreciation | 15.3 | 6.0 | 29.8 | 3.0 | 54.1 | |||||||||||||||
Capital expenditures | 17.0 | 6.9 | 29.9 | 9.1 | 62.9 | |||||||||||||||
Assets | ||||||||||||||||||||
As of March 31, 2016 | $ | 1,024.6 | $ | 562.7 | $ | 1,983.8 | $ | 374.0 | $ | 3,945.1 | ||||||||||
As of December 31, 2015 | 943.7 | 490.0 | 1,757.2 | 346.3 | 3,537.2 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Segment income from operations | $ | 67.1 | $ | 99.1 | |||
Corporate expenses | (29.7 | ) | (29.0 | ) | |||
Stock compensation expense | (5.1 | ) | (2.2 | ) | |||
Restructuring and other infrequent expenses | (1.9 | ) | (10.6 | ) | |||
Amortization of intangibles | (11.0 | ) | (10.5 | ) | |||
Consolidated income from operations | $ | 19.4 | $ | 46.8 |
March 31, 2016 | December 31, 2015 | ||||||
Segment assets | $ | 3,945.1 | $ | 3,537.2 | |||
Cash and cash equivalents | 247.9 | 426.7 | |||||
Receivables from affiliates | 103.2 | 70.1 | |||||
Investments in affiliates | 419.0 | 392.9 | |||||
Deferred tax assets, other current and noncurrent assets | 556.2 | 448.6 | |||||
Intangible assets, net | 535.6 | 507.7 | |||||
Goodwill | 1,169.2 | 1,114.5 | |||||
Consolidated total assets | $ | 6,976.2 | $ | 6,497.7 |
Three Months Ended March 31, | |||||||
2016 | 2015 | ||||||
Revenues | $ | 77.8 | $ | 82.3 | |||
Costs | 41.5 | 46.7 | |||||
Income before income taxes | $ | 36.3 | $ | 35.6 |
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
Three Months Ended March 31, | Change | Change Due to Currency Translation | |||||||||||||||||||
2016 | 2015 | $ | % | $ | % | ||||||||||||||||
North America | $ | 408.4 | $ | 472.5 | $ | (64.1 | ) | (13.6 | )% | $ | (9.1 | ) | (1.9 | )% | |||||||
South America | 144.2 | 249.0 | (104.8 | ) | (42.1 | )% | (52.0 | ) | (20.9 | )% | |||||||||||
Europe/Africa/Middle East | 924.1 | 908.1 | 16.0 | 1.8 | % | (22.5 | ) | (2.5 | )% | ||||||||||||
Asia/Pacific | 82.6 | 73.0 | 9.6 | 13.2 | % | (4.6 | ) | (6.3 | )% | ||||||||||||
$ | 1,559.3 | $ | 1,702.6 | $ | (143.3 | ) | (8.4 | )% | $ | (88.2 | ) | (5.2 | )% |
Three Months Ended March 31, | ||||||||||||||
2016 | 2015 | |||||||||||||
$ | % of Net Sales(1) | $ | % of Net Sales | |||||||||||
Gross profit | $ | 314.7 | 20.2 | % | $ | 347.9 | 20.4 | % | ||||||
Selling, general and administrative expenses | 211.2 | 13.5 | % | 211.2 | 12.4 | % | ||||||||
Engineering expenses | 71.2 | 4.6 | % | 68.8 | 4.0 | % | ||||||||
Restructuring and other infrequent expenses | 1.9 | 0.1 | % | 10.6 | 0.6 | % | ||||||||
Amortization of intangibles | 11.0 | 0.7 | % | 10.5 | 0.6 | % | ||||||||
Income from operations | $ | 19.4 | 1.2 | % | $ | 46.8 | 2.8 | % |
(1) | Rounding may impact summation of amounts. |
• | Our €300.0 million (or approximately $338.0 million as of April 26, 2016) of funding through new term loan agreements (see further discussion below). |
• | Our revolving credit and term loan facility, consisting of an $800.0 million multi-currency revolving credit facility and a €312.0 million (or approximately $355.4 million as of March 31, 2016) term loan facility, which expires in June 2020. As of March 31, 2016, $303.1 million was outstanding under the multi-currency revolving credit facility and €312.0 million (or approximately $355.4 million) was outstanding under the term loan facility (see further discussion below). |
• | Our €200.0 million (or approximately $227.8 million as of March 31, 2016) 1.056% senior term loan, which matures in 2020 (see further discussion below). |
• | Our $307.5 million of 57/8% senior notes, which mature in 2021 (see further discussion below). |
• | Our accounts receivable sales agreements with our finance joint ventures in the United States, Canada, Europe and Brazil. As of March 31, 2016, approximately $1.1 billion of cash had been received under these agreements (see further discussion below). |
• | general economic and capital market conditions; |
• | availability of credit to our retail customers; |
• | the worldwide demand for agricultural products; |
• | grain stock levels and the levels of new and used field inventories; |
• | government policies and subsidies; |
• | weather conditions; |
• | interest and foreign currency exchange rates; |
• | pricing and product actions taken by competitors; |
• | commodity prices, acreage planted and crop yields; |
• | farm income, land values, debt levels and access to credit; |
• | pervasive livestock diseases; |
• | production disruptions; |
• | production levels and capacity constraints at our facilities, including those resulting from plant expansions and systems upgrades; |
• | integration of recent and future acquisitions; |
• | our expansion plans in emerging markets; |
• | supply constraints; |
• | our cost reduction and control initiatives; |
• | our research and development efforts; |
• | dealer and distributor actions; |
• | regulations affecting privacy and data protection; |
• | technological difficulties; and |
• | political and economic uncertainty in various areas of the world. |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
ITEM 4. | CONTROLS AND PROCEDURES |
PART II. | OTHER INFORMATION |
ITEM 1. | LEGAL PROCEEDINGS |
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) | Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)(1)(3) | ||||||||||
January 1, 2016 through January 31, 2016 (2) | 407,607 | $ | 47.20 | 407,607 | $ | 244.2 | ||||||||
February 1, 2016 through February 29, 2016 (3) | 974,619 | $ | 49.25 | 974,619 | $ | 184.2 | ||||||||
March 1, 2016 through March 31, 2016 | — | $ | — | — | $ | 184.2 | ||||||||
Total | 1,382,226 | $ | 47.95 | 1,382,226 | $ | 184.2 |
ITEM 6. | EXHIBITS |
Exhibit Number | Description of Exhibit | The filings referenced for incorporation by reference are AGCO Corporation | ||
10.1 | Credit Agreement dated as of April 26, 2016 | Filed herewith | ||
10.2 | Credit Agreement dated as of April 26, 2016 | Filed herewith | ||
31.1 | Certification of Martin Richenhagen | Filed herewith | ||
31.2 | Certification of Andrew H. Beck | Filed herewith | ||
32.1 | Certification of Martin Richenhagen and Andrew H. Beck | Furnished herewith | ||
101.INS | XBRL Instance Document | Filed herewith | ||
101.SCH | XBRL Taxonomy Extension Schema | Filed herewith | ||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | Filed herewith | ||
101.DEF | XBRL Taxonomy Extension Definition Linkbase | Filed herewith | ||
101.LAB | XBRL Taxonomy Extension Label Linkbase | Filed herewith | ||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase | Filed herewith |
Date: | May 6, 2016 | AGCO CORPORATION Registrant /s/ Andrew H. Beck | |
Andrew H. Beck Senior Vice President and Chief Financial Officer (Principal Financial Officer) |
Page | ||||
ARTICLE 1. DEFINITIONS AND ACCOUNTING TERMS | 1 | |||
Certain Defined Terms | 1 | |||
Computation of Time Periods | 19 | |||
Accounting Terms; Applicable Margin Ratings | 19 | |||
Currency Equivalents | 20 | |||
Incorporation by Reference of Provisions in the AGCO Revolving Credit Agreement | 20 | |||
Construction | 21 | |||
22 | ||||
The Term Loan | 22 | |||
Making the Term Loan | 22 | |||
Reduction of the Commitments | 22 | |||
Repayments and Prepayments | 22 | |||
Interest | 23 | |||
Minimum Interest Rates and Payments | 23 | |||
Continuation of Interest Periods | 24 | |||
Payments and Computations | 24 | |||
Sharing of Payments, Etc | 25 | |||
Intentionally Omitted | 26 | |||
Defaulting Lenders | 26 | |||
27 | ||||
Conditions Precedent to Agreement Date | 27 | |||
Determinations Under Section 3.1 | 30 | |||
Status as a Qualifying Bank or Non-Qualifying Bank | 30 | |||
30 | ||||
Representations and Warranties of AGCO and the Borrower | 30 | |||
AGCO Revolving Credit Agreement Representations | 33 | |||
Swiss Non-Bank Rules | 34 | |||
Survival of Representations and Warranties, etc | 34 | |||
34 | ||||
Incorporation of AGCO Affirmative Covenants | 34 | |||
Swiss Non-Bank Rule | 34 | |||
Amendments to AGCO Revolving Credit Agreement | 34 | |||
35 | ||||
Incorporation of AGCO Information Covenants | 35 | |||
Additional Reporting Requirement for the Borrower | 35 | |||
35 | ||||
Incorporation of AGCO Negative Covenants | 35 | |||
Indebtedness | 35 | |||
Fundamental Changes to the Borrower | 35 | |||
Anti-Terrorism Laws | 36 |
Page | ||||
36 | ||||
Events of Default | 36 | |||
Remedies | 38 | |||
Intentionally Omitted | 38 | |||
Application of Payments | 38 | |||
39 | ||||
Authorization and Action | 39 | |||
Administrative Agent’s Reliance, Etc | 39 | |||
Administrative Agent, in its Individual Capacity and Affiliates | 41 | |||
Lender Credit Decision | 42 | |||
Notice of Default or Event of Default | 42 | |||
Indemnification | 42 | |||
Successor Administrative Agent | 43 | |||
Administrative Agent May File Proofs of Claim | 43 | |||
44 | ||||
Amendments, Etc | 44 | |||
Notices, Etc | 45 | |||
No Waiver; Remedies | 46 | |||
Costs and Expenses | 46 | |||
Right of Set-off | 47 | |||
Binding Effect | 48 | |||
Assignments and Participations | 48 | |||
Marshalling; Payments Set Aside | 53 | |||
Intentionally Omitted | 54 | |||
Intentionally Omitted | 54 | |||
Patriot Act | 54 | |||
Limitations on Obligations of the Borrower | 54 | |||
Acknowledgement and Consent to Bail-In of EEA Financial Institutions | 55 | |||
56 | ||||
Increased Costs, Alternate Rate of Interest, Illegality, Etc | 56 | |||
Breakage Costs | 58 | |||
Judgment Currency | 59 | |||
Taxes | 59 | |||
Mitigation; Replacement of a Lender | 63 | |||
65 | ||||
Consent to Jurisdiction | 65 | |||
Governing Law | 65 | |||
Counterparts; Integration; Effectiveness; Electronic Execution | 66 | |||
Intentionally Omitted | 66 | |||
Intentionally Omitted | 66 | |||
Waiver of Jury Trial | 66 |
Page | ||||
66 | ||||
EXHIBITS AND SCHEDULES: | ||||
Exhibit A | Form of Assignment and Assumption |
Level | Net Leverage Ratio | Applicable Margin |
I | Greater than or equal to 2.50 to 1.00 | 1.75% |
II | Greater than or equal to 1.75 to 1.00 but less than 2.50 to 1.00 | 1.50% |
III | Greater than or equal to 1.00 to 1.00 but less than 1.75 to 1.00 | 1.25% |
IV | Less than 1.00 to 1.00 | 1.00% |
BORROWER: | AGCO INTERNATIONAL GMBH | |||
By: | /s/ Roger Batkin | |||
Name: Roger Batkin | ||||
Title: Vice President, General Counsel and Corporate Secretary | ||||
AGCO: | AGCO CORPORATION | |||
By: | /s/ David Williams | |||
Name: David Williams | ||||
Title: Vice President and Treasurer | ||||
ADMINISTRATIVE AGENT: | COÖPERATIEVE RABOBANK U.A., ANTWERP BRANCH, as the Administrative Agent | |||
By: | /s/ Wendy Bodson | |||
Name: Wendy Bodson | ||||
Title: Head Mid Office | ||||
By: | /s/ Johan Vanhulle | |||
Name: Johna Vanhulle | ||||
Title: General Manager | ||||
LENDER: | PANDIOS S.A., as a Lender | |||
By: | /s/ Barry McGrath | |||
Name: Barry McGrath | ||||
Title: Director | ||||
By: | /s/ Ivo Van den Nest | |||
Name: Ivo Van den Nest | ||||
Title: Director | ||||
Commitment: € 100,000,000 |
1. | Assignor: | _________________________ |
2. | Assignee: | _________________________ |
3. | Status of Assignee: | Assignee is a [Qualifying Bank/Non-Qualifying Bank] [and is an Affiliate/Approved Fund of [identify Lender]1]. |
4. | Borrower: | AGCO International GmbH. |
5. | Administrative Agent: | Coöperatieve Rabobank U.A., Antwerp Branch, as the |
administrative agent under the Credit Agreement. | ||
1 | Select as applicable. |
Aggregate Amount of Commitment/Term Loan for all Lenders | Amount of Commitment/Term Loan Assigned | Percentage Assigned of Commitment/Term Loan2 |
$ | $ | % |
______________________________ |
[NAME OF ASSIGNOR], as Assignor | ||||
By: | _______________________________ | |||
Name:__________________________ | ||||
Title:___________________________ | ||||
Date: | _____________________,20_______ | |||
[NAME OF ASSIGNEE], as Assignee | ||||
By: | _______________________________ | |||
Name: _________________________ | ||||
Title: _________________________ | ||||
Date: | _____________________,20_______ | |||
ACCEPTED AND APPROVED THIS ____ | ||||
DAY OF _________, | __________,_______,20_____ | |||
COÖPERATIEVE RABOBANK U.A., ANTWERP BRANCH, as Administrative Agent5 | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
AGCO INTERNATIONAL GMBH6 | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
Page | ||||
ARTICLE 1. DEFINITIONS AND ACCOUNTING TERMS | 1 | |||
Certain Defined Terms | 1 | |||
Computation of Time Periods | 19 | |||
Accounting Terms; Applicable Margin Ratings | 19 | |||
Currency Equivalents | 20 | |||
Incorporation by Reference of Provisions in the AGCO Revolving Credit Agreement | 20 | |||
Construction | 21 | |||
22 | ||||
The Term Loan | 22 | |||
Making the Term Loan | 22 | |||
Reduction of the Commitments | 22 | |||
Repayments and Prepayments | 22 | |||
Interest | 23 | |||
Minimum Interest Rates and Payments | 23 | |||
Continuation of Interest Periods | 24 | |||
Payments and Computations | 24 | |||
Sharing of Payments, Etc | 25 | |||
Intentionally Omitted | 26 | |||
Defaulting Lenders | 26 | |||
27 | ||||
Conditions Precedent to Agreement Date | 27 | |||
Determinations Under Section 3.1 | 30 | |||
Status as a Qualifying Bank or Non-Qualifying Bank | 30 | |||
30 | ||||
Representations and Warranties of AGCO and the Borrower | 30 | |||
AGCO Revolving Credit Agreement Representations | 34 | |||
Swiss Non-Bank Rules | 34 | |||
Survival of Representations and Warranties, etc | 34 | |||
34 | ||||
Incorporation of AGCO Affirmative Covenants | 34 | |||
Swiss Non-Bank Rule | 34 | |||
Amendments to AGCO Revolving Credit Agreement | 34 | |||
35 | ||||
Incorporation of AGCO Information Covenants | 35 | |||
Additional Reporting Requirement for the Borrower | 35 | |||
35 | ||||
Incorporation of AGCO Negative Covenants | 35 | |||
Indebtedness | 35 | |||
Fundamental Changes to the Borrower | 35 | |||
Anti-Terrorism Laws | 36 |
Page | ||||
36 | ||||
Events of Default | 36 | |||
Remedies | 38 | |||
Intentionally Omitted | 38 | |||
Application of Payments | 38 | |||
39 | ||||
Authorization and Action | 39 | |||
Administrative Agent’s Reliance, Etc | 39 | |||
Administrative Agent, in its Individual Capacity and Affiliates | 41 | |||
Lender Credit Decision | 42 | |||
Notice of Default or Event of Default | 42 | |||
Indemnification | 42 | |||
Successor Administrative Agent | 43 | |||
Administrative Agent May File Proofs of Claim | 43 | |||
44 | ||||
Amendments, Etc | 44 | |||
Notices, Etc | 45 | |||
No Waiver; Remedies | 46 | |||
Costs and Expenses | 46 | |||
Right of Set-off | 47 | |||
Binding Effect | 48 | |||
Assignments and Participations | 48 | |||
Marshalling; Payments Set Aside | 53 | |||
Intentionally Omitted | 54 | |||
Intentionally Omitted | 54 | |||
Patriot Act | 54 | |||
Limitations on Obligations of the Borrower | 54 | |||
Acknowledgement and Consent to Bail-In of EEA Financial Institutions | 55 | |||
56 | ||||
Increased Costs, Alternate Rate of Interest, Illegality, Etc | 56 | |||
Breakage Costs | 58 | |||
Judgment Currency | 59 | |||
Taxes | 59 | |||
Mitigation; Replacement of a Lender | 63 | |||
65 | ||||
Consent to Jurisdiction | 65 | |||
Governing Law | 65 | |||
Counterparts; Integration; Effectiveness; Electronic Execution | 66 | |||
Intentionally Omitted | 66 | |||
Intentionally Omitted | 66 | |||
Waiver of Jury Trial | 66 |
Page | ||||
66 | ||||
EXHIBITS AND SCHEDULES: | ||||
Exhibit A | Form of Assignment and Assumption |
Level | Net Leverage Ratio | Applicable Margin |
I | Greater than or equal to 2.50 to 1.00 | 1.75% |
II | Greater than or equal to 1.75 to 1.00 but less than 2.50 to 1.00 | 1.50% |
III | Greater than or equal to 1.00 to 1.00 but less than 1.75 to 1.00 | 1.25% |
IV | Less than 1.00 to 1.00 | 1.00% |
BORROWER: | AGCO INTERNATIONAL GMBH | |||
By: | /s/ Roger Batkin | |||
Name: Roger Batkin | ||||
Title: Vice President, General Counsel and Corporate Secretary | ||||
AGCO: | AGCO CORPORATION | |||
By: | /s/ David Williams | |||
Name: David Williams | ||||
Title: Vice President and Treasurer | ||||
ADMINISTRATIVE AGENT: | COÖPERATIEVE RABOBANK U.A., ANTWERP BRANCH, as the Administrative Agent | |||
By: | /s/ Wendy Bodson | |||
Name: Wendy Bodson | ||||
Title: Head Mid Office | ||||
By: | /s/ Johan Vanhulle | |||
Name: Johna Vanhulle | ||||
Title: General Manager | ||||
LENDER: | COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, as a Lender | |||
By: | /s/ Sarah Fleet | |||
Name: Sarah Fleet | ||||
Title: Vice President | ||||
By: | /s/ Michael T. Harder | |||
Name: Michael T. Harder | ||||
Title: Executive Director | ||||
Commitment: € 200,000,000 |
1. | Assignor: | _________________________ |
2. | Assignee: | _________________________ |
3. | Status of Assignee: | Assignee is a [Qualifying Bank/Non-Qualifying Bank] [and is an Affiliate/Approved Fund of [identify Lender]1]. |
4. | Borrower: | AGCO International GmbH. |
5. | Administrative Agent: | Coöperatieve Rabobank U.A., Antwerp Branch, as the |
administrative agent under the Credit Agreement. | ||
1 | Select as applicable. |
Aggregate Amount of Commitment/Term Loan for all Lenders | Amount of Commitment/Term Loan Assigned | Percentage Assigned of Commitment/Term Loan2 |
$ | $ | % |
______________________________ |
[NAME OF ASSIGNOR], as Assignor | ||||
By: | _______________________________ | |||
Name:__________________________ | ||||
Title:___________________________ | ||||
Date: | _____________________,20_______ | |||
[NAME OF ASSIGNEE], as Assignee | ||||
By: | _______________________________ | |||
Name:__________________________ | ||||
Title:___________________________ | ||||
Date: | _____________________,20_______ | |||
ACCEPTED AND APPROVED THIS ____ | ||||
DAY OF _________, | __________,_______,20_____ | |||
COÖPERATIEVE RABOBANK U.A., ANTWERP BRANCH, as Administrative Agent5 | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
AGCO INTERNATIONAL GMBH6 | ||||
By: | _________________________ | |||
Name:____________________ | ||||
Title:_____________________ | ||||
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | May 6, 2016 | |
/s/ Martin Richenhagen | ||
Martin Richenhagen | ||
Chairman of the Board, President and Chief Executive Officer |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | May 6, 2016 | |
/s/ Andrew H. Beck | ||
Andrew H. Beck | ||
Senior Vice President and Chief Financial Officer |
/s/ Martin Richenhagen | ||
Martin Richenhagen | ||
Chairman of the Board, President and Chief Executive Officer | ||
May 6, 2016 | ||
/s/Andrew H. Beck | ||
Andrew H. Beck | ||
Senior Vice President and Chief Financial Officer | ||
May 6, 2016 |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Apr. 29, 2016 |
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | AGCO CORP /DE | |
Entity Central Index Key | 0000880266 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2016 | |
Document Fiscal Year Focus | 2016 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 82,474,201 |
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preferred stock, par value, in dollars per share | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value, in dollars per share | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 150,000,000 | 150,000,000 |
Common stock, shares issued | 82,458,100 | 83,814,809 |
Common stock, shares outstanding | 82,458,100 | 83,814,809 |
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 10.2 | $ 29.9 |
Other comprehensive income (loss), net of reclassification adjustments: | ||
Foreign currency translation adjustments | 94.8 | (344.2) |
Defined benefit pension plans, net of tax | 2.2 | 2.2 |
Unrealized loss on derivatives, net of tax | (2.7) | (1.6) |
Other comprehensive income (loss), net of reclassification adjustments | 94.3 | (343.6) |
Comprehensive income (loss) | 104.5 | (313.7) |
Comprehensive (income) loss attributable to noncontrolling interests | (2.4) | 0.1 |
Comprehensive income (loss) attributable to AGCO Corporation and subsidiaries | $ 102.1 | $ (313.6) |
Basis of Presentation |
3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||
Basis of Presentation | BASIS OF PRESENTATION The condensed consolidated financial statements of AGCO Corporation and its subsidiaries (the “Company” or “AGCO”) included herein have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to present fairly the Company’s financial position, results of operations, comprehensive income (loss) and cash flows at the dates and for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Results for interim periods are not necessarily indicative of the results for the year. Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, “Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the accounting for forfeitures, employer tax withholding on share-based compensation and the financial statement presentation of excess tax benefits or deficiencies. In addition, the standard clarifies the statement of cash flow presentation for certain components of share-based awards. The application methods are specific to each component of the ASU and may be applied using a prospective, retrospective or a modified retrospective approach. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. The Company is currently evaluating the impact of adopting this standard on the Company’s results of operations, financial condition and cash flows. In February 2016, the FASB issued ASU 2016-02, “Leases” (“ASU 2016-02”), which supersedes the existing lease guidance under current U.S. GAAP. ASU 2016-02 is based on the principle that entities should recognize assets and liabilities arising from leases. The standard does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. ASU 2016-02’s primary change is the requirement for entities to recognize a lease liability for payments and a right-of-use asset representing the right to use the leased asset during the term of an operating lease arrangement. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of 12 months or less. Lessors’ accounting under the standard is largely unchanged from the previous accounting standard. In addition, ASU 2016-02 expands the disclosure requirements of lease arrangements. The standard is effective for reporting periods beginning after December 15, 2018, and interim periods within those annual periods. Early adoption is permitted. Upon adoption, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The Company is currently evaluating the impact of adopting this standard on the Company’s results of operations and financial condition. In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”), which changes the measurement principle for inventory from the “lower of cost or market” to “lower of cost and net realizable value.” The new principle applies to entities that measure inventory using a method other than the last-in, first-out (“LIFO”) or the retail inventory methods. Entities using the first-in, first-out (“FIFO”) or average cost methods of measuring inventory no longer will need to consider replacement cost or net realizable value less an approximate normal profit margin in the subsequent measurement of inventory. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The standard does not amend or change the determination of the cost of inventory. The standard is effective prospectively for inventory measurements for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company expects the adoption of ASU 2015-11 on January 1, 2017 will not have a material impact on its results of operations and financial condition. In April 2015, the FASB issued ASU 2015-05, “Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” (“ASU 2015-05”). ASU 2015-05 provides guidance about whether a cloud computing arrangement includes a software license and how to account for cloud computing arrangements when a software license is included or excluded. The standard is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted. The standard may be applied either prospectively to all arrangements entered into or materially modified after the effective date, or retrospectively. The adoption of ASU 2015-05 on January 1, 2016 did not have a material impact on the results of operations and financial condition. In April 2015, the FASB issued ASU 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of a deferred charge. Given the absence of authoritative guidance within ASU 2015-03, in August 2015 the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” (“ASU 2015-15”), which clarifies that the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. ASU 2015-03 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption was permitted. The Company adopted this standard effective January 1, 2016 and has applied the requirements of ASU 2015-03 retrospectively to all periods presented. In the Condensed Consolidated Balance Sheet as of December 31, 2015, the Company reclassified approximately $3.6 million as a decrease to “Other assets” and correspondingly decreased “Long-term debt” by approximately $3.6 million. The debt issuance costs related to the Company’s multi-currency revolving credit facility continue to be classified within “Other assets” in the Condensed Consolidated Balance Sheets as permitted by the standard. In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes existing revenue recognition guidance under current U.S. GAAP. ASU 2014-09 outlines a comprehensive, single revenue recognition model that provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers at an amount that reflects the consideration expected to be received in exchange for those goods or services. Additional disclosures also will be required to enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for reporting periods beginning after December 15, 2016 using either a full retrospective or a modified retrospective approach. Early adoption is not permitted. On July 9, 2015, the FASB delayed the effective date of ASU 2014-09 by one year or to reporting periods beginning after December 15, 2017. Early adoption is permitted, but not any earlier than the original effective date. Subsequent to ASU 2014-09, the FASB issued several related ASUs:
The Company is currently evaluating the impact of adopting these standards on the Company’s results of operations and financial condition. |
Acquisitions |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions | ACQUISITIONS On February 2, 2016, the Company acquired Tecno Poultry Equipment S.p.A (“Tecno”) for approximately €53.5 million (or approximately $57.9 million). The Company acquired cash of approximately €17.6 million (or approximately $19.1 million) associated with the acquisition. Tecno, headquartered in Marsango di Campo San Martino, Italy, manufactures and supplies poultry housing and related products, including egg collection equipment and trolley feeding systems. The acquisition was financed through the Company’s credit facility (Note 6). The Company allocated the purchase price to the assets acquired and liabilities assumed based on preliminary estimates of their fair values as of the acquisition date. The acquired net assets primarily consisted of accounts receivable, inventories, accounts payable and accrued expenses, deferred revenue, property, plant and equipment, and customer relationship, technology and trademark identifiable intangible assets. The Company recorded approximately $27.5 million of customer relationship, technology and trademark identifiable intangible assets and approximately $15.2 million of goodwill associated with the acquisition. The results of operations of Tecno have been included in the Company’s Consolidated Financial Statements as of and from the date of acquisition. The acquired identifiable intangible assets of Tecno as of the date of the acquisition are summarized in the following table (in millions):
|
Restructuring and Other Infrequent Expenses |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Infrequent Expenses | RESTRUCTURING AND OTHER INFREQUENT EXPENSES During 2015 and 2014, the Company announced and initiated several actions to rationalize employee headcount at various manufacturing facilities and administrative offices located in Europe, China, South America and the United States. The aggregate headcount reduction of approximately 2,100 employees during 2014 and 2015 was initiated in order to reduce costs in response to softening global market demand and reduced production volumes. During 2014 and 2015, the Company expensed and paid an aggregate of $68.7 million and $48.5 million, respectively, associated with these rationalizations, of which a majority related to severance and other related costs. The Company had approximately $16.9 million of severance and related costs accrued as of December 31, 2015. During the three months ended March 31, 2016, the Company recorded an additional $1.9 million of severance and related costs associated with further rationalizations in the United States, South America and Europe, associated with the termination of approximately 200 employees. The Company paid approximately $3.4 million of severance and associated costs during the first quarter of 2016. The remaining $16.0 million of accrued severance and other related costs as of March 31, 2016, inclusive of approximately $0.6 million of positive foreign currency translation impacts, are expected to be paid primarily during 2016. |
Stock Compensation Plans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Compensation Plans | STOCK COMPENSATION PLANS The Company recorded stock compensation expense as follows for the three months ended March 31, 2016 and 2015 (in millions):
Stock Incentive Plan Under the Company’s 2006 Long Term Incentive Plan (the “2006 Plan”), up to 10,000,000 shares of AGCO common stock may be issued. The 2006 Plan allows the Company, under the direction of the Board of Directors’ Compensation Committee, to make grants of performance shares, stock appreciation rights, restricted stock units and restricted stock awards to employees, officers and non-employee directors of the Company. Long-Term Incentive Plan and Related Performance Awards The weighted average grant-date fair value of performance awards granted under the 2006 Plan during the three months ended March 31, 2016 and 2015 was $47.94 and $42.46, respectively. During the three months ended March 31, 2016, the Company granted 1,327,042 performance awards related to varying performance periods. The awards granted assume the maximum target level of performance is achieved, as applicable. The compensation expense associated with all awards granted under the 2006 Plan is amortized ratably over the vesting or performance period based on the Company’s projected assessment of the level of performance that will be achieved and earned. Performance award transactions during the three months ended March 31, 2016 were as follows and are presented as if the Company were to achieve its maximum levels of performance under the plan awards:
As of March 31, 2016, the total compensation cost related to unearned performance awards not yet recognized, assuming the Company’s current projected assessment of the level of performance that will be achieved and earned, was approximately $62.8 million, and the weighted average period over which it is expected to be recognized is approximately three years. Restricted Stock Unit Awards During the three months ended March 31, 2016, the Company granted 137,496 restricted stock unit (“RSU”) awards. These awards entitle the participant to receive one share of the Company’s common stock for each RSU granted and vest one-third per year over a three-year requisite service period. For RSU awards granted in 2015, dividends will accrue on all unvested grants until the end of each vesting date within the three-year requisite service period. In January 2016, the Company amended its RSU award agreement such that dividends will not accrue on unvested grants over the requisite service period on all future RSU grants. The compensation expense associated with these awards is amortized ratably over the requisite service period for the awards that are expected to vest. The weighted average grant-date fair value of the RSUs granted under the 2006 Plan during the three months ended March 31, 2016 and 2015 was $45.05 and $43.88, respectively. RSU transactions during the three months ended March 31, 2016 were as follows:
As of March 31, 2016, the total compensation cost related to the unvested RSUs not yet recognized was approximately $9.3 million, and the weighted average period over which it is expected to be recognized is approximately two years. Stock-Settled Appreciation Rights During the three months ended March 31, 2016 and 2015, the Company recorded stock compensation expense of approximately $1.0 million and $1.3 million, respectively, associated with stock-settled appreciation rights (“SSAR”) awards. The Company estimated the fair value of the grants using the Black-Scholes option pricing model. The weighted average grant-date fair value of SSARs granted under the 2006 Plan and the weighted average assumptions under the Black-Scholes option pricing model were as follows for the three months ended March 31, 2016 and 2015:
SSAR transactions during the three months ended March 31, 2016 were as follows:
At March 31, 2016, the weighted average remaining contractual life of SSARs outstanding was approximately four years. As of March 31, 2016, the total compensation cost related to unvested SSARs not yet recognized was approximately $7.1 million, and the weighted-average period over which it is expected to be recognized is approximately three years. The following table sets forth the exercise price range, number of shares, weighted average exercise price and remaining contractual life by groups of similar price as of March 31, 2016:
The total fair value of SSARs vested during the three months ended March 31, 2016 was approximately $3.8 million. There were 748,846 SSARs that were not vested as of March 31, 2016. The total intrinsic value of outstanding and exercisable SSARs as of March 31, 2016 was $4.5 million and $2.2 million, respectively. The total intrinsic value of SSARs exercised during the three months ended March 31, 2016 was less than $0.1 million. The Company realized an insignificant tax benefit from the exercise of these SSARs. Director Restricted Stock Grants The 2006 Plan provides for annual restricted stock grants of the Company’s common stock to all non-employee directors. The 2016 grant was made on April 28, 2016 and equated to 20,232 shares of common stock, of which 15,395 shares of common stock were issued after shares were withheld for taxes. The Company recorded stock compensation expense of approximately $1.1 million during the three months ended June 30, 2016 associated with these grants. As of March 31, 2016, of the 10,000,000 shares reserved for issuance under the 2006 Plan, approximately 2,587,122 shares were available for grant, assuming the maximum number of shares are earned related to the performance award grants discussed above. |
Goodwill and Other Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Other Intangible Assets | GOODWILL AND OTHER INTANGIBLE ASSETS Changes in the carrying amount of acquired intangible assets during the three months ended March 31, 2016 are summarized as follows (in millions):
The Company currently amortizes certain acquired intangible assets, primarily on a straight-line basis, over their estimated useful lives, which range from five to 50 years. Changes in the carrying amount of goodwill during the three months ended March 31, 2016 are summarized as follows (in millions):
Goodwill is tested for impairment on an annual basis and more often if indications of impairment exist. The Company conducts its annual impairment analyses as of October 1 each fiscal year. |
Indebtedness |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indebtedness [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indebtedness | INDEBTEDNESS Indebtedness consisted of the following at March 31, 2016 and December 31, 2015 (in millions):
4 1/2% Senior Term Loan The Company’s €200.0 million (or approximately $227.8 million as of March 31, 2016) 41/2% senior term loan with Coöperatieve Centrale Raiffeisen-Boerenleenbank B.A. (“Rabobank”) was due May 2, 2016. The Company had the ability to prepay the term loan before its maturity date. Interest was payable on the term loan at 41/2% per annum, payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each year. The term loan contained covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends, and was subject to acceleration in the event of default. The Company also had to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. On April 26, 2016, the Company entered into two term loan agreements with Rabobank, in the amount of €100.0 million and €200.0 million, respectively. The €300.0 million (or approximately $338.0 million) of funding was received on April 26, 2016 and was partially used to repay the Company’s €200.0 million (or approximately $225.4 million) 4½% senior term loan with Rabobank which was due May 2, 2016, for net proceeds of approximately €99.6 million (or approximately $112.2 million) after debt issuance costs. The provisions of the two term loans are identical in nature. The Company has the ability to prepay the term loans before their maturity date on April 26, 2021. Interest is payable on the term loans per annum, equal to the EURIBOR plus a margin ranging from 1.0% to 1.75% based on the Company’s net leverage ratio. Interest is paid quarterly in arrears on April 26, July 26, October 26, and January 26 of each year. The term loan contains certain covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends, and is subject to acceleration in the event of default. The Company also has to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. Credit Facility The Company’s revolving credit and term loan facility consists of an $800.0 million multi-currency revolving credit facility and a €312.0 million (or approximately $355.4 million as of March 31, 2016) term loan facility. The Company is not required to make quarterly payments towards the term loan facility and the maturity date of the Company’s credit facility is June 26, 2020. Under the credit facility agreement, interest accrues on amounts outstanding, at the Company’s option, depending on the currency borrowed, at either (1) LIBOR or EURIBOR plus a margin ranging from 1.0% to 1.75% based on the Company’s leverage ratio, or (2) the base rate, which is equal to the higher of (i) the administrative agent’s base lending rate for the applicable currency, (ii) the federal funds rate plus 0.5%, and (iii) one-month LIBOR for loans denominated in U.S. dollars plus 1.0% plus a margin ranging from 0.0% to 0.25% based on the Company’s leverage ratio. As is more fully described in Note 11, the Company entered into an interest rate swap in 2015 to convert the term loan facility’s floating interest rate to a fixed interest rate of 0.33% plus the applicable margin over the remaining life of the term loan facility. The credit facility contains covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends, and is subject to acceleration in the event of a default. The Company also has to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. As of March 31, 2016, the Company had $658.5 million of outstanding borrowings under the credit facility and availability to borrow approximately $496.9 million under the facility. Approximately $303.1 million was outstanding under the multi-currency revolving credit facility and €312.0 million (or approximately $355.4 million) was outstanding under the term loan facility as of March 31, 2016. As of December 31, 2015, no amounts were outstanding under the Company’s multi-currency revolving credit facility, and the Company had the ability to borrow approximately $800.0 million under the facility. Approximately, €312.0 million (or approximately $338.9 million) was outstanding under the term loan facility as of December 31, 2015. During 2015, the Company designated its €312.0 million ($355.4 million as of March 31, 2016) term loan facility as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. See Note 11 for additional information about the net investment hedge. 1.056% Senior Term Loan In December 2014, the Company entered into a term loan with the European Investment Bank, which provided the Company with the ability to borrow up to €200.0 million. The €200.0 million (or approximately $227.8 million as of March 31, 2016) of funding was received on January 15, 2015 with a maturity date of January 15, 2020. The Company has the ability to prepay the term loan before its maturity date. Interest is payable on the term loan at 1.056% per annum, payable quarterly in arrears on January 15, April 15, July 15 and October 15 of each year. The term loan contains covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, as well as commitments regarding amounts of future research and development expenses in Europe, and is subject to acceleration in the event of default. The Company also has to fulfill financial covenants with respect to a net leverage ratio and an interest coverage ratio. 5 7/8% Senior Notes The Company’s $307.5 million of 57/8% senior notes due December 1, 2021 constitute senior unsecured and unsubordinated indebtedness. Interest is payable on the notes semi-annually in arrears on June 1 and December 1 of each year. At any time prior to September 1, 2021, the Company may redeem the notes, in whole or in part from time to time, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount plus accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of interest accrued to the date of redemption) discounted to the redemption date at the treasury rate plus 0.5%, plus accrued and unpaid interest, including additional interest, if any. Beginning September 1, 2021, the Company may redeem the notes, in whole or in part from time to time, at its option, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, including additional interest, if any. As is more fully described in Note 11, the Company entered into an interest rate swap in 2015 to convert the senior notes’ fixed interest rate to a floating interest rate over the remaining life of the senior notes. A weighted average interest rate of 4.52% was applicable from the date of inception of the interest rate swap to March 31, 2016. Standby Letters of Credit and Similar Instruments The Company has arrangements with various banks to issue standby letters of credit or similar instruments, which guarantee the Company’s obligations for the purchase or sale of certain inventories and for potential claims exposure for insurance coverage. At March 31, 2016 and December 31, 2015, outstanding letters of credit totaled $17.7 million and $17.5 million, respectively. |
Inventories |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | INVENTORIES Inventories at March 31, 2016 and December 31, 2015 were as follows (in millions):
|
Product Warranty |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Warranties Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Warranty | PRODUCT WARRANTY The warranty reserve activity for the three months ended March 31, 2016 and 2015 consisted of the following (in millions):
The Company’s agricultural equipment products generally are warranted against defects in material and workmanship for a period of one to four years. The Company accrues for future warranty costs at the time of sale based on historical warranty experience. Approximately $205.8 million and $195.2 million of warranty reserves are included in “Accrued expenses” in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015, respectively. Approximately $35.9 million and $35.1 million of warranty reserves are included in “Other noncurrent liabilities” in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015, respectively. |
Net Income Per Common Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income Per Common Share | NET INCOME PER COMMON SHARE Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted net income per common share assumes the exercise of outstanding stock-settled appreciation rights (“SSARs”) and the vesting of performance share awards and restricted stock units using the treasury stock method when the effects of such assumptions are dilutive. A reconciliation of net income attributable to AGCO Corporation and its subsidiaries and weighted average common shares outstanding for purposes of calculating basic and diluted net income per share for the three months ended March 31, 2016 and 2015 is as follows (in millions, except per share data):
SSARs to purchase approximately 1.5 million shares of the Company’s common stock for the three months ended March 31, 2016 and approximately 1.3 million shares of the Company’s common stock for the three months ended March 31, 2015 were outstanding but not included in the calculation of weighted average common and common equivalent shares outstanding because they had an antidilutive impact. |
Income Taxes |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | INCOME TAXES At March 31, 2016 and December 31, 2015, the Company had approximately $143.5 million and $133.0 million, respectively, of unrecognized tax benefits, all of which would affect the Company’s effective tax rate if recognized. At March 31, 2016 and December 31, 2015, the Company had approximately $64.7 million and $61.2 million, respectively, of accrued or deferred taxes related to uncertain income tax positions connected with ongoing income tax audits in various jurisdictions that it expects to settle or pay in the next 12 months. The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. At March 31, 2016 and December 31, 2015, the Company had accrued interest and penalties related to unrecognized tax benefits of $20.7 million and $18.3 million, respectively. Generally, tax years 2010 through 2015 remain open to examination by taxing authorities in the United States and certain other foreign taxing jurisdictions. |
Derivative Instruments and Hedging Activities |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities | DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES All derivatives are recognized on the Company’s Condensed Consolidated Balance Sheets at fair value. On the date the derivative contract is entered into, the Company designates the derivative as either (1) a fair value hedge of a recognized liability, (2) a cash flow hedge of a forecasted transaction, (3) a hedge of a net investment in a foreign operation, or (4) a non-designated derivative instrument. The Company formally documents all relationships between hedging instruments and hedged items, as well as the risk management objectives and strategy for undertaking various hedge transactions. The Company formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flow of hedged items or the net investment hedges in foreign operations. When it is determined that a derivative is no longer highly effective as a hedge, hedge accounting is discontinued on a prospective basis. The Company categorizes its derivative assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. See Note 15 for a discussion of the fair value hierarchy as per the guidance in Accounting Standards Codification 820, “Fair Value Measurements.” The Company’s valuation techniques are designed to maximize the use of observable inputs and minimize the use of unobservable inputs. Foreign Currency and Interest Rate Risk The Company has significant manufacturing operations in the United States, France, Germany, Finland and Brazil, and it purchases a portion of its tractors, combines and components from third-party foreign suppliers, primarily in various European countries and in Japan. The Company also sells products in over 140 countries throughout the world. The Company’s most significant transactional foreign currency exposures are the Euro, the Brazilian real and the Canadian dollar in relation to the United States dollar and the Euro in relation to the British pound. The Company attempts to manage its transactional foreign exchange exposure by hedging foreign currency cash flow forecasts and commitments arising from the anticipated settlement of receivables and payables and from future purchases and sales. Where naturally offsetting currency positions do not occur, the Company hedges certain, but not all, of its exposures through the use of foreign currency contracts. The Company’s translation exposure resulting from translating the financial statements of foreign subsidiaries into United States dollars may be partially hedged from time to time. The Company’s most significant translation exposures are the Euro, the British pound and the Brazilian real in relation to the United States dollar and the Swiss franc in relation to the Euro. When practical, the translation impact is reduced by financing local operations with local borrowings. The Company uses floating rate and fixed rate debt to finance its operations. The floating rate debt obligations expose the Company to variability in interest payments due to changes in the EURIBOR and LIBOR benchmark interest rates. The Company believes it is prudent to limit the variability of a portion of its interest payments, and to meet that objective, the Company periodically enters into interest rate swaps to manage the interest rate risk associated with the Company’s borrowings. The Company designates interest rate contracts used to convert the interest rate exposure on a portion of the Company’s debt portfolio from a floating rate to a fixed rate as cash flow hedges, while those contracts converting the Company’s interest rate exposure from a fixed rate to a floating rate are designated as fair value hedges. The Company’s senior management establishes the Company’s foreign currency and interest rate risk management policies. These policies are reviewed periodically by the Finance Committee of the Company’s Board of Directors. The policies allow for the use of derivative instruments to hedge exposures to movements in foreign currency and interest rates. The Company’s policies prohibit the use of derivative instruments for speculative purposes. Counterparty Risk The Company regularly monitors the counterparty risk and credit ratings of all the counterparties to the derivative instruments. The Company believes that its exposures are appropriately diversified across counterparties and that these counterparties are creditworthy financial institutions. If the Company perceives any risk with a counterparty, then the Company would cease to do business with that counterparty. There have been no negative impacts to the Company from any non-performance of any counterparties. Derivative Transactions Designated as Hedging Instruments Foreign Currency Contracts During 2016, no foreign currency contracts were designated as cash flow hedges of expected future sales and purchases. The Company designated certain foreign currency contracts as cash flow hedges of expected future sales and purchases during 2015. The effective portion of the fair value gains or losses on these cash flow hedges were recorded in other comprehensive loss and were subsequently reclassified into cost of goods sold during the period the sales and purchases were recognized. These amounts offset the effect of the changes in foreign currency rates on the related sale and purchase transactions. The amount of the net loss recorded in other comprehensive loss that was reclassified into cost of goods sold during the three months ended March 31, 2015 was approximately $0.3 million on an after-tax basis. As of March 31, 2016 and December 31, 2015, there were no outstanding foreign currency cash flow hedge contracts. Interest Rate Swap Contracts Cash Flow Hedge During the third quarter of 2015, the Company entered into an interest rate swap instrument with a notional amount of €312.0 million (or approximately $355.4 million as of March 31, 2016) and an expiration date of June 26, 2020. The swap was designated and accounted for as a cash flow hedge. Under the swap agreement, the Company pays a fixed interest rate of 0.33% plus the applicable margin, and the counterparty to the agreement pays a floating interest rate based on the three-month EURIBOR. Changes in the fair value of the interest rate swap are recorded in other comprehensive income (loss). These amounts are subsequently reclassified into “Interest expense, net” as a rate adjustment in the same period in which the related interest on the Company’s floating rate term loan facility affects earnings. For the three months ended March 31, 2016, the effective portion of the unrealized change in fair value, net of tax, was a loss of approximately $4.7 million, which was recorded in other comprehensive income. The amount of the net loss recorded in other comprehensive income that was reclassified into “Interest expense, net” during the three months ended March 31, 2016 was approximately $0.2 million, on an after-tax basis. There was no ineffectiveness during the three months ended March 31, 2016. Fair Value Hedge During the third quarter of 2015, the Company entered into an interest rate swap instrument with a notional amount of $300.0 million and an expiration date of December 1, 2021 designated as a fair value hedge of the Company’s 57/8% senior notes (Note 6). Under the interest rate swap, the Company pays a floating interest rate based on the three-month LIBOR plus a spread of 4.14% (or a weighted average interest rate of 4.52% from the date of inception of the interest rate swap to March 31, 2016) and the counterparty to the agreement pays a fixed interest rate of 57/8%. The gains and losses related to changes in the fair value of the interest rate swap are recorded to “Interest expense, net” and offset changes in the fair value of the underlying hedged 57/8% senior notes. For the three months ended March 31, 2016, the Company recorded unrealized losses on the hedged debt of approximately $7.5 million in “Interest expense, net” in the Condensed Consolidated Statements of Operations. The unrealized gains of approximately $7.5 million on the related interest rate swap instrument offset such unrealized losses, and were also recorded in “Interest expense, net” in the Condensed Consolidated Statements of Operations. The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the three months ended March 31, 2016 (in millions):
Net Investment Hedges The Company uses non-derivative and, from time to time, derivative instruments, to hedge a portion of its net investment in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based on changes in forward rates. For instruments that are designated as hedges of net investments in foreign operations, changes in the fair value of the derivative instruments are recorded in foreign currency translation adjustments, a component of accumulated other comprehensive loss, to offset changes in the value of the net investments being hedged. When the net investment in foreign operations is sold or substantially liquidates, the amounts recorded in accumulated other comprehensive loss are reclassified to earnings. To the extent foreign currency denominated debt is dedesignated from a net investment hedge relationship, changes in the value of the foreign currency denominated debt are recorded in earnings through the maturity date. During 2015, the Company designated its €312.0 million (or approximately $355.4 million as of March 31, 2016) term loan facility with a maturity date of June 26, 2020 as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. As of March 31, 2016, approximately $9.0 million of foreign currency losses were included in the cumulative translation adjustment component of accumulated other comprehensive loss. There was no ineffectiveness with respect to the net investment hedge discussed above during the three months ended March 31, 2016. Derivative Transactions Not Designated as Hedging Instruments During 2016 and 2015, the Company entered into foreign currency contracts to economically hedge receivables and payables on the Company and its subsidiaries’ balance sheets that are denominated in foreign currencies other than the functional currency. These contracts were classified as non-designated derivative instruments. As of March 31, 2016 and December 31, 2015, the Company had outstanding foreign currency contracts with a notional amount of approximately $1,644.2 million and $1,533.9 million, respectively, that were entered into to economically hedge receivables and payables that were denominated in foreign currencies other than the functional currency. Changes in the fair value of these contracts are reported in “Other (income) expense, net.” For the three months ended March 31, 2016 and 2015, the Company recorded a net gain of approximately $8.3 million and a net loss of $45.7 million, respectively, within “Other (income) expense, net” related to these contracts. Gains and losses on such contracts are substantially offset by losses and gains on the remeasurement of the underlying asset or liability being hedged. The table below sets forth the fair value of derivative instruments as of March 31, 2016 (in millions):
The table below sets forth the fair value of derivative instruments as of December 31, 2015 (in millions):
|
Changes in Stockholders' Equity |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Stockholders' Equity | CHANGES IN STOCKHOLDERS’ EQUITY The following table sets forth changes in stockholders’ equity attributed to AGCO Corporation and its subsidiaries and to noncontrolling interests for the three months ended March 31, 2016 (in millions):
Total comprehensive income (loss) attributable to noncontrolling interests for the three months ended March 31, 2016 and 2015 was as follows (in millions):
The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2016 (in millions):
The following table sets forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2016 and 2015 (in millions):
____________________________________ (1) Losses included within the Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015. (2) These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. See Note 14 to the Company’s Condensed Consolidated Financial Statements. Share Repurchase Program During the three months ended March 31, 2016, the Company entered into an accelerated share repurchase (“ASR”)agreement with a financial institution to repurchase an aggregate of $60.0 million of shares of the Company’s common stock. The Company received approximately 974,619 shares during the three months ended March 31, 2016 related to the ASR agreement. All shares received under the ASR agreement were retired upon receipt, and the excess of the purchase price over par value per share was recorded to “Additional paid-in capital” within the Company’s Condensed Consolidated Balance Sheets. The specific number of shares the Company will ultimately repurchase will be determined at the completion of the term of the ASR based on the daily volume-weighted average share price of the Company’s common stock less an agreed upon discount. Upon settlement of the ASR, the Company may be entitled to receive additional shares of common stock, or under certain circumstances, be required to remit a settlement amount. The Company expects that additional shares will be received by the Company upon final settlement of its current ASR, which expires during the second quarter of 2016. Of the $1,050.0 million in approved share repurchase programs, the remaining amount authorized to be repurchased is approximately $184.2 million. |
Accounts Receivable Sales Agreements |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Accounts Receivable Sales Agreements [Abstract] | |
Accounts Receivable Sales Agreements | ACCOUNTS RECEIVABLE SALES AGREEMENTS As of March 31, 2016 and December 31, 2015, the Company had accounts receivable sales agreements that permit the sale, on an ongoing basis, of a majority of its wholesale receivables in North America and Europe to its 49% owned U.S., Canadian and European finance joint ventures. The Company also had an accounts receivable sales agreement that permits the sale, on an ongoing basis, of a portion of its wholesale receivables in Brazil to its Brazilian finance joint venture. As of both March 31, 2016 and December 31, 2015, the cash received from receivables sold under the U.S., Canadian, European and Brazilian accounts receivable sales agreements was approximately $1.1 billion. Under the terms of the accounts receivable agreements in North America, Europe and Brazil, the Company pays an annual servicing fee related to the servicing of the receivables sold. The Company also pays the respective AGCO Finance entities a subsidized interest payment with respect to the sales agreements, calculated based upon LIBOR plus a margin on any non-interest bearing accounts receivable outstanding and sold under the sales agreements. These fees were reflected within losses on the sales of receivables included within “Other expense, net” in the Company’s Condensed Consolidated Statements of Operations. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. The Company reviewed its accounting for the accounts receivable sales agreements and determined that these facilities should be accounted for as off-balance sheet transactions. Losses on sales of receivables associated with the accounts receivable financing facilities discussed above, reflected within “Other expense, net” in the Company’s Condensed Consolidated Statements of Operations, were approximately $4.8 million and $5.0 million during the three months ended March 31, 2016 and 2015, respectively. The Company’s finance joint ventures in Brazil and Australia also provide wholesale financing directly to the Company’s dealers. The receivables associated with these arrangements are without recourse to the Company. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. As of March 31, 2016 and December 31, 2015, these finance joint ventures had approximately $17.3 million and $17.7 million, respectively, of outstanding accounts receivable associated with these arrangements. The Company reviewed its accounting for these arrangements and determined that these arrangements should be accounted for as off-balance sheet transactions. In addition, the Company sells certain trade receivables under factoring arrangements to other financial institutions around the world. The Company reviewed the sale of such receivables and determined that these arrangements should be accounted for as off-balance sheet transactions. |
Employee Benefit Plans |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Benefit Plans | EMPLOYEE BENEFIT PLANS Net periodic pension and postretirement benefit cost for the Company’s defined pension and postretirement benefit plans for the three months ended March 31, 2016 and 2015 are set forth below (in millions):
The following table summarizes the activity in accumulated other comprehensive loss related to the Company’s defined pension and postretirement benefit plans during the three months ended March 31, 2016 (in millions):
During the three months ended March 31, 2016, approximately $10.0 million of contributions had been made to the Company’s defined pension benefit plans. The Company currently estimates its minimum contributions for 2016 to its defined pension benefit plans will aggregate approximately $31.6 million. During the three months ended March 31, 2016, the Company made approximately $0.4 million of contributions to its postretirement health care and life insurance benefit plans. The Company currently estimates that it will make approximately $1.5 million of contributions to its postretirement health care and life insurance benefit plans during 2016. |
Fair Value of Financial Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | FAIR VALUE OF FINANCIAL INSTRUMENTS The Company categorizes its assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. Estimates of fair value for financial assets and liabilities are based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. In accordance with this guidance, fair value measurements are classified under the following hierarchy: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - Model-derived valuations in which one or more significant inputs are unobservable. The Company categorizes its pension plan assets into one of the three levels of the fair value hierarchy. The Company enters into foreign currency and interest rate swap contracts. The fair values of the Company’s derivative instruments are determined using discounted cash flow valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these discounted cash flow valuation models for derivative instruments include the applicable exchange rates, forward rates or interest rates. Such models used for option contracts also use implied volatility. See Note 11 for a discussion of the Company’s derivative instruments and hedging activities. The Company’s trading securities consist of foreign-based government bonds. The fair value of the Company’s investments in trading securities classified as Level 2 are priced using nonbinding market prices that are corroborated by observable market data. Assets and liabilities measured at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 are summarized below (in millions):
The carrying amounts of long-term debt under the Company’s 41/2% senior term loan, credit facility and 1.056% senior term loan (Note 6) approximate fair value based on the borrowing rates currently available to the Company for loans with similar terms and average maturities. |
Segment Reporting |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting | SEGMENT REPORTING The Company’s four reportable segments distribute a full range of agricultural equipment and related replacement parts. The Company evaluates segment performance primarily based on income (loss) from operations. Sales for each segment are based on the location of the third-party customer. The Company’s selling, general and administrative expenses and engineering expenses are charged to each segment based on the region and division where the expenses are incurred. As a result, the components of income (loss) from operations for one segment may not be comparable to another segment. Segment results for the three months ended March 31, 2016 and 2015 and assets as of March 31, 2016 and December 31, 2015 based on the Company’s reportable segments are as follows (in millions):
A reconciliation from the segment information to the consolidated balances for income from operations and total assets is set forth below (in millions):
|
Commitments and Contingencies |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES Off-Balance Sheet Arrangements Guarantees The Company maintains a remarketing agreement with its U.S. finance joint venture, whereby the Company is obligated to repurchase repossessed inventory at market values. The Company has an agreement with its U.S. finance joint venture, AGCO Finance LLC, which limits the Company’s purchase obligations under this arrangement to $6.0 million in the aggregate per calendar year. The Company believes that any losses that might be incurred on the resale of this equipment will not materially impact the Company’s financial position or results of operations, due to the fair value of the underlying equipment. At March 31, 2016, the Company has outstanding guarantees of indebtedness owed to third parties of approximately $49.0 million, primarily related to dealer and end-user financing of equipment. Such guarantees generally obligate the Company to repay outstanding finance obligations owed to financial institutions if dealers or end users default on such loans through 2020. The Company believes the credit risk associated with these guarantees is not material to its financial position or results of operations. Losses under such guarantees have historically been insignificant. In addition, the Company generally would expect to be able to recover a significant portion of the amounts paid under such guarantees from the sale of the underlying financed farm equipment, as the fair value of such equipment is expected to be sufficient to offset a substantial portion of the amounts paid. Other The Company sells a majority of its wholesale receivables in North America and Europe to its 49% owned U.S., Canadian and European finance joint ventures, and a portion of its wholesale receivables in Brazil to its Brazilian finance joint venture. The Company also sells certain accounts receivable under factoring arrangements to financial institutions around the world. The Company reviewed the sale of such receivables and determined that these facilities should be accounted for as off-balance sheet transactions. Legal Claims and Other Matters In August 2008, as part of routine audits, the Brazilian taxing authorities disallowed deductions relating to the amortization of certain goodwill recognized in connection with a reorganization of the Company’s Brazilian operations and the related transfer of certain assets to the Company’s Brazilian subsidiaries. The amount of the tax disallowance through March 31, 2016, not including interest and penalties, was approximately 131.5 million Brazilian reais (or approximately $36.6 million). The amount ultimately in dispute will be greater because of interest and penalties. The Company has been advised by its legal and tax advisors that its position with respect to the deductions is allowable under the tax laws of Brazil. The Company is contesting the disallowance and believes that it is not likely that the assessment, interest or penalties will be required to be paid. However, the ultimate outcome will not be determined until the Brazilian tax appeal process is complete, which could take several years. The Company is a party to various other legal claims and actions incidental to its business. The Company believes that none of these claims or actions, either individually or in the aggregate, is material to its business or financial statements as a whole, including its results of operations and financial condition. |
Investments in Affiliates |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Affiliates | INVESTMENTS IN AFFILIATES Summarized combined financial information of the Company’s finance joint ventures for the three months ended March 31, 2016 and 2015 were as follows (in millions):
|
Basis of Presentation (Policies) |
3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||
Recent Accounting Pronouncements | Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, “Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the accounting for forfeitures, employer tax withholding on share-based compensation and the financial statement presentation of excess tax benefits or deficiencies. In addition, the standard clarifies the statement of cash flow presentation for certain components of share-based awards. The application methods are specific to each component of the ASU and may be applied using a prospective, retrospective or a modified retrospective approach. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. The Company is currently evaluating the impact of adopting this standard on the Company’s results of operations, financial condition and cash flows. In February 2016, the FASB issued ASU 2016-02, “Leases” (“ASU 2016-02”), which supersedes the existing lease guidance under current U.S. GAAP. ASU 2016-02 is based on the principle that entities should recognize assets and liabilities arising from leases. The standard does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. ASU 2016-02’s primary change is the requirement for entities to recognize a lease liability for payments and a right-of-use asset representing the right to use the leased asset during the term of an operating lease arrangement. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of 12 months or less. Lessors’ accounting under the standard is largely unchanged from the previous accounting standard. In addition, ASU 2016-02 expands the disclosure requirements of lease arrangements. The standard is effective for reporting periods beginning after December 15, 2018, and interim periods within those annual periods. Early adoption is permitted. Upon adoption, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The Company is currently evaluating the impact of adopting this standard on the Company’s results of operations and financial condition. In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”), which changes the measurement principle for inventory from the “lower of cost or market” to “lower of cost and net realizable value.” The new principle applies to entities that measure inventory using a method other than the last-in, first-out (“LIFO”) or the retail inventory methods. Entities using the first-in, first-out (“FIFO”) or average cost methods of measuring inventory no longer will need to consider replacement cost or net realizable value less an approximate normal profit margin in the subsequent measurement of inventory. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The standard does not amend or change the determination of the cost of inventory. The standard is effective prospectively for inventory measurements for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company expects the adoption of ASU 2015-11 on January 1, 2017 will not have a material impact on its results of operations and financial condition. In April 2015, the FASB issued ASU 2015-05, “Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement” (“ASU 2015-05”). ASU 2015-05 provides guidance about whether a cloud computing arrangement includes a software license and how to account for cloud computing arrangements when a software license is included or excluded. The standard is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted. The standard may be applied either prospectively to all arrangements entered into or materially modified after the effective date, or retrospectively. The adoption of ASU 2015-05 on January 1, 2016 did not have a material impact on the results of operations and financial condition. In April 2015, the FASB issued ASU 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of a deferred charge. Given the absence of authoritative guidance within ASU 2015-03, in August 2015 the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” (“ASU 2015-15”), which clarifies that the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. ASU 2015-03 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption was permitted. The Company adopted this standard effective January 1, 2016 and has applied the requirements of ASU 2015-03 retrospectively to all periods presented. In the Condensed Consolidated Balance Sheet as of December 31, 2015, the Company reclassified approximately $3.6 million as a decrease to “Other assets” and correspondingly decreased “Long-term debt” by approximately $3.6 million. The debt issuance costs related to the Company’s multi-currency revolving credit facility continue to be classified within “Other assets” in the Condensed Consolidated Balance Sheets as permitted by the standard. In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes existing revenue recognition guidance under current U.S. GAAP. ASU 2014-09 outlines a comprehensive, single revenue recognition model that provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers at an amount that reflects the consideration expected to be received in exchange for those goods or services. Additional disclosures also will be required to enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for reporting periods beginning after December 15, 2016 using either a full retrospective or a modified retrospective approach. Early adoption is not permitted. On July 9, 2015, the FASB delayed the effective date of ASU 2014-09 by one year or to reporting periods beginning after December 15, 2017. Early adoption is permitted, but not any earlier than the original effective date. Subsequent to ASU 2014-09, the FASB issued several related ASUs:
The Company is currently evaluating the impact of adopting these standards on the Company’s results of operations and financial condition. |
||||||||
Derivatives | All derivatives are recognized on the Company’s Condensed Consolidated Balance Sheets at fair value. On the date the derivative contract is entered into, the Company designates the derivative as either (1) a fair value hedge of a recognized liability, (2) a cash flow hedge of a forecasted transaction, (3) a hedge of a net investment in a foreign operation, or (4) a non-designated derivative instrument. The Company formally documents all relationships between hedging instruments and hedged items, as well as the risk management objectives and strategy for undertaking various hedge transactions. The Company formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flow of hedged items or the net investment hedges in foreign operations. When it is determined that a derivative is no longer highly effective as a hedge, hedge accounting is discontinued on a prospective basis. |
Acquisitions (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of acquired identifiable intangible assets | The acquired identifiable intangible assets of Tecno as of the date of the acquisition are summarized in the following table (in millions):
|
Stock Compensation Plans (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Compensation Expense | The Company recorded stock compensation expense as follows for the three months ended March 31, 2016 and 2015 (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Performance Award Transactions | Performance award transactions during the three months ended March 31, 2016 were as follows and are presented as if the Company were to achieve its maximum levels of performance under the plan awards:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Unit Award Transactions | RSU transactions during the three months ended March 31, 2016 were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted Average Grant-Date Fair Value of SSARs and Assumptions Under Black-Scholes Option Model | The weighted average grant-date fair value of SSARs granted under the 2006 Plan and the weighted average assumptions under the Black-Scholes option pricing model were as follows for the three months ended March 31, 2016 and 2015:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SSAR Activity | SSAR transactions during the three months ended March 31, 2016 were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of SSAR Exercise Price Range, Number Of Shares, Weighted Average Exercise Price and Remaining Contractual Lives | The following table sets forth the exercise price range, number of shares, weighted average exercise price and remaining contractual life by groups of similar price as of March 31, 2016:
|
Goodwill and Other Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets by Major Class | Changes in the carrying amount of acquired intangible assets during the three months ended March 31, 2016 are summarized as follows (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Indefinite-lived Intangible Assets by Major Class |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill | Changes in the carrying amount of goodwill during the three months ended March 31, 2016 are summarized as follows (in millions):
|
Indebtedness (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indebtedness [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components Of Indebtedness | Indebtedness consisted of the following at March 31, 2016 and December 31, 2015 (in millions):
|
Inventories (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventory | Inventories at March 31, 2016 and December 31, 2015 were as follows (in millions):
|
Product Warranty (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Warranties Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Warranty Reserve Activity | The warranty reserve activity for the three months ended March 31, 2016 and 2015 consisted of the following (in millions):
|
Net Income Per Common Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calculation Of Basic And Diluted Earnings Per Share | A reconciliation of net income attributable to AGCO Corporation and its subsidiaries and weighted average common shares outstanding for purposes of calculating basic and diluted net income per share for the three months ended March 31, 2016 and 2015 is as follows (in millions, except per share data):
|
Derivative Instruments and Hedging Activities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary Of Accumulated Other Comprehensive Loss Related To Derivatives | The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the three months ended March 31, 2016 (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Of Derivative Instruments | The table below sets forth the fair value of derivative instruments as of March 31, 2016 (in millions):
The table below sets forth the fair value of derivative instruments as of December 31, 2015 (in millions):
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 are summarized below (in millions):
|
Changes in Stockholders' Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Stockholders Equity | The following table sets forth changes in stockholders’ equity attributed to AGCO Corporation and its subsidiaries and to noncontrolling interests for the three months ended March 31, 2016 (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Comprehensive Income (Loss) | Total comprehensive income (loss) attributable to noncontrolling interests for the three months ended March 31, 2016 and 2015 was as follows (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Accumulated Other Comprehensive (Loss) Income | The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2016 (in millions):
The following table summarizes the activity in accumulated other comprehensive loss related to the Company’s defined pension and postretirement benefit plans during the three months ended March 31, 2016 (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassification Out Of Accumulated Other Comprehensive Loss | The following table sets forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2016 and 2015 (in millions):
____________________________________ (1) Losses included within the Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015. (2) These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. See Note 14 to the Company’s Condensed Consolidated Financial Statements. |
Employee Benefit Plans (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Accumulated Other Comprehensive Income | The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2016 (in millions):
The following table summarizes the activity in accumulated other comprehensive loss related to the Company’s defined pension and postretirement benefit plans during the three months ended March 31, 2016 (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension Benefits [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Pension And Postretirement Cost | Net periodic pension and postretirement benefit cost for the Company’s defined pension and postretirement benefit plans for the three months ended March 31, 2016 and 2015 are set forth below (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Postretirement Benefits [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Pension And Postretirement Cost |
|
Fair Value of Financial Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Of Derivative Instruments | The table below sets forth the fair value of derivative instruments as of March 31, 2016 (in millions):
The table below sets forth the fair value of derivative instruments as of December 31, 2015 (in millions):
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 are summarized below (in millions):
|
Segment Reporting (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sales Information By Reportable Segments | Segment results for the three months ended March 31, 2016 and 2015 and assets as of March 31, 2016 and December 31, 2015 based on the Company’s reportable segments are as follows (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Income From Operations from Segment to Consolidated | A reconciliation from the segment information to the consolidated balances for income from operations and total assets is set forth below (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Assets from Segment to Consolidated |
|
Investments in Affiliates (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments | Summarized combined financial information of the Company’s finance joint ventures for the three months ended March 31, 2016 and 2015 were as follows (in millions):
|
Basis of Presentation Recent Accounting Pronouncements (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Debt issuance costs | $ 3.5 | $ 3.6 |
Other Assets [Member] | Accounting Standards Update 2015-03 [Member] | ||
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Debt issuance costs | (3.6) | |
Long-term Debt [Member] | Accounting Standards Update 2015-03 [Member] | ||
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Debt issuance costs | $ 3.6 |
Restructuring and Other Infrequent Expenses (Details) $ in Millions |
3 Months Ended | 12 Months Ended | 24 Months Ended | ||
---|---|---|---|---|---|
Mar. 31, 2016
USD ($)
employees
|
Mar. 31, 2015
USD ($)
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2015
USD ($)
employees
|
|
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and related cost, headcount reduction | employees | 200 | 2,100 | |||
Payments for restructuring | $ 3.4 | $ 48.5 | $ 68.7 | ||
Restructuring and other infrequent expenses | 1.9 | $ 10.6 | |||
Restructuring reserve | 16.0 | $ 16.9 | $ 16.9 | ||
Foreign currency translation impacting severance and other related costs | 0.6 | ||||
Employee Severance [Member] | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and other infrequent expenses | $ 1.9 |
Stock Compensation Plans (Schedule of Employee Service Share-based Compensation, Allocation of Recognized Costs) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock compensation expense | $ 5.5 | $ 2.4 |
Cost of goods sold [Member] | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock compensation expense | 0.4 | 0.2 |
Selling, general and administrative expenses [Member] | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock compensation expense | $ 5.1 | $ 2.2 |
Stock Compensation Plans (Performance Award Transactions) (Details) - Performance Shares [Member] |
3 Months Ended |
---|---|
Mar. 31, 2016
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward] | |
Shares awarded but not earned, beginning of period | 1,449,396 |
Shares awarded | 1,327,042 |
Shares forfeited or unearned | (11,248) |
Shares earned | 0 |
Shares awarded but not earned, end of period | 2,765,190 |
Stock Compensation Plans (Restricted Stock Unit Award Transactions) (Details) - Restricted Stock Units (RSUs) [Member] |
3 Months Ended |
---|---|
Mar. 31, 2016
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward] | |
Shares awarded but not earned, beginning of period | 137,396 |
Shares awarded | 137,496 |
Shares forfeited or unearned | (1,358) |
Shares earned | (46,137) |
Shares awarded but not earned, end of period | 227,397 |
Stock Compensation Plans (Weighted Average Grant-Date Fair Value Of SSARS And Assumptions Under Black-Scholes Option Model) (Details) - Settled Stock Appreciation Rights (SSARs) [Member] - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted average grant-date fair value of performance awards granted, dollars per share | $ 7.98 | $ 7.41 |
Weighted average assumptions under Black-Scholes option model: | ||
Expected life of awards, years | 3 years | 3 years |
Risk-free interest rate, percent | 1.10% | 0.90% |
Expected volatility, percent | 25.90% | 25.90% |
Expected dividend yield, percent | 1.10% | 1.10% |
Goodwill and Other Intangible Assets (Indefinite-Lived Intangible Assets) (Details) - Trademarks and Tradenames [Member] $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Indefinite-lived intangible assets: | |
Balance at beginning of period | $ 85.3 |
Foreign currency translation | 1.5 |
Balance at end of period | $ 86.8 |
Goodwill and Other Intangible Assets (Schedule of Goodwill) (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Goodwill | |
Goodwill at beginning of period | $ 1,114.5 |
Acquisitions | 24.8 |
Foreign currency translation | 29.9 |
Goodwill at end of period | 1,169.2 |
North America [Member] | |
Goodwill | |
Goodwill at beginning of period | 518.7 |
Acquisitions | 16.4 |
Foreign currency translation | 0.0 |
Goodwill at end of period | 535.1 |
South America [Member] | |
Goodwill | |
Goodwill at beginning of period | 114.4 |
Acquisitions | 0.0 |
Foreign currency translation | 11.5 |
Goodwill at end of period | 125.9 |
Europe/Africa/Middle East [Member] | |
Goodwill | |
Goodwill at beginning of period | 425.2 |
Acquisitions | 8.4 |
Foreign currency translation | 15.9 |
Goodwill at end of period | 449.5 |
Asia/Pacific [Member] | |
Goodwill | |
Goodwill at beginning of period | 56.2 |
Acquisitions | 0.0 |
Foreign currency translation | 2.5 |
Goodwill at end of period | $ 58.7 |
Inventories (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Inventory Disclosure [Abstract] | ||
Finished goods | $ 688.6 | $ 523.1 |
Repair and replacement parts | 568.1 | 515.4 |
Work in process | 130.4 | 97.5 |
Raw materials | 338.7 | 287.4 |
Inventories, net | $ 1,725.8 | $ 1,423.4 |
Product Warranty (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
|
Warranty reserve activity: | |||
Balance at beginning of period | $ 230.3 | $ 284.6 | |
Acquisitions | 0.6 | 0.0 | |
Accruals for warranties issued during the period | 44.0 | 34.0 | |
Settlements made (in cash or in kind) during the period | (40.6) | (44.9) | |
Foreign currency translation | 7.4 | (20.8) | |
Balance at end of period | $ 241.7 | $ 252.9 | |
Product warranty period, minimum, years | 1 year | ||
Product warranty period, maximum, years | 4 years | ||
Product warranty accrual, current | $ 205.8 | $ 195.2 | |
Product warranty accrual, noncurrent | $ 35.9 | $ 35.1 |
Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Basic net income per share: | ||
Net income attributable to AGCO Corporation and subsidiaries | $ 7.8 | $ 30.1 |
Weighted average number of common shares outstanding, shares | 83.0 | 88.8 |
Basic net income per share attributable to AGCO Corporation and subsidiaries, dollars per share | $ 0.09 | $ 0.34 |
Diluted net income per share: | ||
Dilutive SSARs, performance share awards and restricted stock awards, shares | 0.1 | 0.2 |
Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted income per share, shares | 83.1 | 89.0 |
Diluted net income per share attributable to AGCO Corporation and subsidiaries, dollars per share | $ 0.09 | $ 0.34 |
Stock Appreciation Rights (SARs) [Member] | ||
Diluted net income per share: | ||
SSARs excluded from earnings per share computation, shares | 1.5 | 1.3 |
Income Taxes (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Income Tax Disclosure [Abstract] | ||
Unrecognized income tax benefits that would affect effective tax rate | $ 143.5 | $ 133.0 |
Accrued or deferred taxes relating to uncertain income tax positions | 64.7 | 61.2 |
Accrued interest and penalties relating to unrecognized tax benefits | $ 20.7 | $ 18.3 |
Derivative Instruments and Hedging Activities (Summary Of Accumulated Other Comprehensive Loss Related To Derivatives) (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Before-Tax Amount | |
Accumulated derivative net losses as of December 31, 2015 | $ (3.3) |
Net changes in fair value of derivatives | (4.8) |
Net losses reclassified from accumulated other comprehensive loss into income | 0.4 |
Accumulated derivative net losses as of March 31, 2016 | (7.7) |
Income Tax | |
Accumulated derivative net losses as of December 31, 2015 | (1.3) |
Net changes in fair value of derivatives | (1.9) |
Net losses reclassified from accumulated other comprehensive loss into income | 0.2 |
Accumulated derivative net losses as of March 31, 2016 | (3.0) |
After-Tax Amount | |
Accumulated derivative net losses as of December 31, 2015 | (2.0) |
Net changes in fair value of derivatives | (2.9) |
Net losses reclassified from accumulated other comprehensive loss into income | 0.2 |
Accumulated derivative net losses as of March 31, 2016 | $ (4.7) |
Changes in Stockholders' Equity (Schedule of Comprehensive Income for Noncontrolling Interest) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract] | ||
Net income (loss) | $ 2.4 | $ (0.2) |
Other comprehensive income: | ||
Foreign currency translation adjustments | 0.0 | 0.1 |
Total comprehensive income (loss) | $ 2.4 | $ (0.1) |
Changes in Stockholders' Equity (Narrative) (Details) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Cost of goods sold | $ 1,244,600,000 | $ 1,354,700,000 | ||
Stock repurchase program, authorized amount | 1,050,000,000 | |||
Stock repurchased and retired during period | 60,000,000 | |||
Stock repurchase program, outstanding balance authorized to be repurchased | 184,200,000 | |||
Accelerated Share Repurchase [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock repurchased and retired during period | $ 60,000,000 | |||
Stock repurchased and retired during period, shares | 974,619 | |||
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Cost of goods sold | [1] | $ 0 | $ 300,000 | |
|
Accounts Receivable Sales Agreements (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2016 |
Dec. 31, 2015 |
Mar. 31, 2015 |
|
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Net cash received from receivables sold | $ 1,100.0 | $ 1,100.0 | |
Outstanding accounts receivable associated with retail finance joint ventures in Brazil and Australia | 17.3 | $ 17.7 | |
Other Expenses, Net [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Loss on sales of receivables | $ 4.8 | $ 5.0 | |
Corporate Joint Venture [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Joint venture ownership percentage | 49.00% | 49.00% |
Employee Benefit Plans (Narrative) (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Defined Benefit Pension Plans [Member] | |
Defined Benefit Plan Disclosure [Line Items] | |
Employer contributions | $ 10.0 |
Estimated minimum contributions | 31.6 |
Postretirement Health Coverage [Member] | |
Defined Benefit Plan Disclosure [Line Items] | |
Employer contributions | 0.4 |
Estimated minimum contributions | $ 1.5 |
Employee Benefit Plans (Net Pension And Postretirement Cost) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Pension Benefits [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | $ 4.1 | $ 4.7 |
Interest cost | 6.4 | 7.8 |
Expected return on plan assets | (10.2) | (11.1) |
Amortization of net actuarial loss | 2.6 | 2.8 |
Amortization of prior service cost | 0.3 | 0.1 |
Net periodic pension or postretirement benefit cost | 3.2 | 4.3 |
Postretirement Benefits [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Interest cost | 0.4 | 0.4 |
Net periodic pension or postretirement benefit cost | $ 0.4 | $ 0.4 |
Employee Benefit Plans (Net Periodic Pension Costs Included in Accumulated Other Comprehensive Income (Loss)) (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Before-Tax Amount | |
Accumulated other comprehensive loss as of December 31, 2015 | $ (336.6) |
Amortization of net actuarial loss | 2.6 |
Amortization of prior service cost | 0.3 |
Accumulated other comprehensive loss as of March 31, 2016 | (333.7) |
Income Tax | |
Accumulated other comprehensive loss as of December 31, 2015 | (87.6) |
Amortization of net actuarial loss | 0.6 |
Amortization of prior service cost | 0.1 |
Accumulated other comprehensive loss as of March 31, 2016 | (86.9) |
After-Tax Amount | |
Accumulated other comprehensive loss as of December 31, 2015 | (249.0) |
Amortization of net actuarial loss | 2.0 |
Amortization of prior service cost | 0.2 |
Accumulated other comprehensive loss as of March 31, 2016 | $ (246.8) |
Fair Value of Financial Instruments (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative asset, fair value | $ 18.4 | $ 4.8 |
Derivative liability, fair value | 21.5 | 13.8 |
Long-term debt, fair value | 307.5 | 297.4 |
Trading securities | 7.2 | 6.6 |
Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative asset, fair value | 18.4 | 4.8 |
Derivative liability, fair value | 21.5 | 13.8 |
Long-term debt, fair value | 307.5 | 297.4 |
Trading securities | $ 7.2 | $ 6.6 |
Segment Reporting (Sales Information By Reportable Segments) (Details) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2016
USD ($)
reportable_segment
|
Mar. 31, 2015
USD ($)
|
Dec. 31, 2015
USD ($)
|
|
Segment Reporting Information [Line Items] | |||
Number of reportable segments, segments | reportable_segment | 4 | ||
Net sales | $ 1,559.3 | $ 1,702.6 | |
(Loss) income from operations | 19.4 | 46.8 | |
Depreciation | 55.5 | 54.1 | |
Capital expenditures | 35.7 | 62.9 | |
Segment assets | 6,976.2 | $ 6,497.7 | |
Operating Segments [Member] | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,559.3 | 1,702.6 | |
(Loss) income from operations | 67.1 | 99.1 | |
Depreciation | 55.5 | 54.1 | |
Capital expenditures | 35.7 | 62.9 | |
Segment assets | 3,945.1 | 3,537.2 | |
North America [Member] | |||
Segment Reporting Information [Line Items] | |||
Net sales | 408.4 | 472.5 | |
(Loss) income from operations | (0.7) | 17.5 | |
Depreciation | 15.6 | 15.3 | |
Capital expenditures | 11.4 | 17.0 | |
Segment assets | 1,024.6 | 943.7 | |
South America [Member] | |||
Segment Reporting Information [Line Items] | |||
Net sales | 144.2 | 249.0 | |
(Loss) income from operations | 0.4 | 13.1 | |
Depreciation | 4.6 | 6.0 | |
Capital expenditures | 6.2 | 6.9 | |
Segment assets | 562.7 | 490.0 | |
Europe/ Africa/ Middle East [Member] | |||
Segment Reporting Information [Line Items] | |||
Net sales | 924.1 | 908.1 | |
(Loss) income from operations | 70.3 | 80.5 | |
Depreciation | 31.7 | 29.8 | |
Capital expenditures | 15.7 | 29.9 | |
Segment assets | 1,983.8 | 1,757.2 | |
Asia/Pacific [Member] | |||
Segment Reporting Information [Line Items] | |||
Net sales | 82.6 | 73.0 | |
(Loss) income from operations | (2.9) | (12.0) | |
Depreciation | 3.6 | 3.0 | |
Capital expenditures | 2.4 | $ 9.1 | |
Segment assets | $ 374.0 | $ 346.3 |
Segment Reporting (Income From Operations And Total Assets) (Details) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Income from Operations | ||||
Segment income from operations | $ 19.4 | $ 46.8 | ||
Stock compensation expense | (5.1) | (2.2) | ||
Restructuring and other infrequent expenses | (1.9) | (10.6) | ||
Amortization of intangibles | (11.0) | (10.5) | ||
(Loss) income from operations | 19.4 | 46.8 | ||
Total Assets | ||||
Segment assets | 6,976.2 | $ 6,497.7 | ||
Cash and cash equivalents | 247.9 | 338.9 | 426.7 | $ 363.7 |
Receivables from affiliates | 103.2 | 70.1 | ||
Investments in affiliates | 419.0 | 392.9 | ||
Deferred tax assets, other current and noncurrent assets | 556.2 | 448.6 | ||
Intangible assets, net | 535.6 | 507.7 | ||
Goodwill | 1,169.2 | 1,114.5 | ||
Consolidated total assets | 6,976.2 | 6,497.7 | ||
Operating Segments [Member] | ||||
Income from Operations | ||||
Segment income from operations | 67.1 | 99.1 | ||
(Loss) income from operations | 67.1 | 99.1 | ||
Corporate, Non-Segment [Member] | ||||
Income from Operations | ||||
Corporate expenses | (29.7) | (29.0) | ||
Operating Segments [Member] | ||||
Income from Operations | ||||
Segment income from operations | 67.1 | 99.1 | ||
(Loss) income from operations | 67.1 | $ 99.1 | ||
Total Assets | ||||
Segment assets | 3,945.1 | 3,537.2 | ||
Consolidated total assets | $ 3,945.1 | $ 3,537.2 |
Commitments and Contingencies (Details) BRL in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2016
USD ($)
|
Mar. 31, 2016
BRL
|
Dec. 31, 2015 |
|
Guarantees [Abstract] | |||
Guaranteed indebtedness owed to third parties | $ 49,000,000 | ||
Loss Contingency [Abstract] | |||
Tax disallowance not including interest and penalties | 36,600,000 | BRL 131.5 | |
Retail Finance Joint Venture [Member] | |||
Guarantees [Abstract] | |||
Maximum repossessed inventory purchase obligation with retail joint ventures | $ 6,000,000.0 | ||
Corporate Joint Venture [Member] | |||
Guarantees [Abstract] | |||
Joint venture ownership percentage | 49.00% | 49.00% | 49.00% |
Investments in Affiliates (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract] | ||
Revenue | $ 77.8 | $ 82.3 |
Cost of Sales | 41.5 | 46.7 |
Income before Income Taxes | $ 36.3 | $ 35.6 |
FS"9 EF.TF8$,7 #
M!;?AP;UJUA.(\H<#?OT'.G1^>Y1F=XS80(EM[M"WGOX"C56 :\+8WTQJNM[G;_^LV'_"U!+ P04
M " #6>J9( PX @XSVFG*!;:=4*^$/*5\"V+QE.A:/,[=[RN
M#,[$I*,=>;C!S2[W!]$0[\W2L!6[#XBZ.M6;LJC8*0A]P!P2)D^8%<&\^EHB
M_W^)0WY!SZ_3BQL.BT@O%H?E=8'RAD 9! @*0#- 5@'Q$9(I_F9"-+4([L&H]G;,U%'" ](
M;L0ND+GQ4#W2U2M$4[\U.,OJ^$T169BMP2"-@1D12_99 JU+;-$B'&>YFP![
M;VY LAF0UQ)G7D"Z&]!]#I,E479\AATU-R1Q0O1D3
ME'L>[U+QY-I %,-"N:0>EU0T];TIXCJZRSB6Y* EB9(D+L714J2K)!+Y5XC$
M Y$H?ZHA$K<_]?A3Y<^T/[411UV$EL1 :< &Q"[5\;G*8LD\+)G)DCE9M*10
MDABHGY/&I[-X<@]/;O+D3I[D#S'O9H0D$@:A*\.1JW
M4O<1497':G5;E.P8A3Y@]AG#,V9!L*"^E.#?E]CS,SK_FKZ^X'"=Z.O9X3?U
M-Q<$-DE@<['%CYC/+MG9F6JP77HZCM0X&I\/;\DNK_.>ISMYAU?E(#KX+6PG
MC2,'].%FT]VTB!Z"B>+JFI(^_)\E4-#ZN+P-:YN?5 X\#J&UL?5/+;MLP$/P5@A\0RI)<%X8L($Y1M(<"00[MF996$A&2JY*4E?Y]
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MXW5E<"8F'>W(PPUN]KD_B(9X;Y:&K=A]0-35N=[LBHJ=@] 'S#%A\H19$%P9&8=+0]#S>XV.;^("KBO5D:
MMF+W 5$6QW*QV13L&(0^8?8)DR?,C&!>?2Z1?U]BGY_1\\OTY16'RTA?3@YO
M+PNLK@BLHL#J:HN?,+?9ER+L[$P5F#8^'4LJ'+1+AS=GY]=Y%R^1?<#+HN
J?-P.=G
ML R=NPT-EJ,S',&:E,_2D%M2E5O*@"JS?RN^!Y_QP7)^L?9F^BP-Y3V?8_"Y
M%2R[%N[/P@2Z[6L6(;SR[_$Y%EF.+= *A<^*".XI&/D
EC ,96E=GI
M0 99!H:Y!LJ!$"Z+2H/U/R(-A(&!AS(J1$O]4E.IE =!,V&*Z_K%"UG2&,/,
M5"UE0]!\F+)UJF0YFV'F&;NB# NI1F4:;\JRD-G,)E)FQ,!B-B>0TC;$-(X,
MVB)E1@2+B?L'%!EX*,&PO=V]R:W-H965T